Your browser is no longer supported. Please, upgrade your browser.
Settings
IWM iShares Russell 2000 daily Stock Chart
IWM [NYSE]
iShares Russell 2000
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.46%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.06%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter14.00%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio3.83 Perf Half Y12.33%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year12.03%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range92.85 - 125.88 Perf YTD10.35%
Dividend1.78 P/FCF- EPS past 5Y- ROI- 52W High-2.11% Beta-
Dividend %1.44% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low32.72% ATR1.51
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)51.07 Volatility1.01% 1.15%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.77 Prev Close124.81
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume25.72M Price123.23
Recom- SMA20-0.04% SMA500.84% SMA20010.04% Volume19,928,895 Change-1.27%
Sep-26-16 05:04PM  Flash US Manufacturing PMI: A Slowdown?
03:04PM  Does Fed Softness Indicate a Weaker Economy?
01:48PM  Reports Of The TED Spreads Death Are Greatly Exaggerated
11:00AM  Performance Snapshot: Top iShares Russell 2000 ETF (IWM) at Investopedia
Sep-24-16 12:10PM  The Week Ahead: Ivy League Investor Flunks Test at Forbes
08:00AM  What to expect from the stock market this week
Sep-23-16 04:42PM  Video Stock Market Analysis 9/23/16
04:37PM  End-of-Q3 challengingfinal five trading days S&P 500 down 7 of last 8 years
08:06AM  Ray Dalio Cautions Investors about the Carry-Price Change Trap
07:00AM  Trader's Daily Notebook: A Little Volatility Wouldn't Hurt
Sep-22-16 12:44PM  How Janet Yellen Rationalizes The Most Pervasive Financial Bubble In History
11:04AM  Jim Chanos Is Still Short on Valeant, Bill Miller Is Positive
10:53AM  What this new trader learned on Day 1 (166 lessons)
08:51AM  Ray Dalio: The Next Downturn May Be a Difficult One to Reverse
Sep-20-16 04:04PM  Junk Bonds Officially Enter Bubble Territory
01:04PM  Back-to-School Shoppers Didnt Help Retail Sales in August
Sep-19-16 05:53PM  Is This Index A Leading Interest Rate Indicator?
09:13AM  Charts Show Market-Tracking ETFs Are Deteriorating
Sep-17-16 02:06PM  Technical Analysis of Markets 9/16/16
11:46AM  The Week Ahead: Should You Care About The 'Bulls No.1 Lie?' at Forbes
08:00AM  What to expect from the stock market this week
Sep-16-16 05:15PM  Apple Product Launches Send Major Indexes Higher (SPY, DIA) at Investopedia
04:04PM  How Does Papa Johns PE Multiple Compare to Its Peers?
02:29PM  S&P 500 down 22 of 26 during week after September options expiration, average loss 1.08%
Sep-15-16 11:46PM  Smaller Stocks Bounce Off Important Line
06:16PM  Why Central Bank Policy Isnt Working And Why That Wont Stop Them
02:41PM  Stop Wasting Energy On The VIX
02:00PM  Stocks Suffer Unprecedented Volatility Shock
11:04AM  Whats the Primary Driver of Corporate Earnings?
10:05AM  Carl Icahn: Either Way, the Market Will Face a Serious Problem
10:05AM  How Lower Interest Rates Elevated Market Valuations
Sep-14-16 06:39PM  Is The Selloff Over -- Or Just Getting Started?
04:00PM  STOCKS GO NOWHERE: Here's what you need to know
02:22PM  S&P 500 Testing An Important Area
12:38PM  Why Goldman Sachs Is Bearish on S&P 500 Index
12:04PM  US Dollar Index: How It Impacted the S&P 500 Indexs Earnings
10:55AM  Man I stink II!
10:39AM  Man I Stink!
10:27AM  Reading the Tape is All You Need
09:43AM  US Business Investment Is Falling: Will Lower Rates Support It?
Sep-13-16 12:17AM  1 > 40
Sep-12-16 08:20PM  Why Higher Rates Are Good For Stocks at Forbes
02:50PM  A Bold Strategy For Bearish Options Traders at Forbes
12:38PM  What to do with a chart that shows no place for investors to hide at MarketWatch
09:25AM  Which Way Are Dow, Nasdaq, S&P Going? Check These Charts
08:04AM  Zero Rates Wouldnt Provide a Cushion When the Recession Rolls In
Sep-10-16 12:22PM  The Week Ahead: Is Global Investing Worth The Risk? at Forbes
12:12PM  Wall Street Sell-off: A Scary Chart For Investors at Forbes
11:54AM  How Concerning Was Fridays Sell-Off?
08:00AM  What to expect from the stock market this week
Sep-09-16 06:03PM  Stocks Dive as Rate Hike Fears Grow (SPY, DIA) at Investopedia
04:38PM  Stock Market Video Analysis 9/9/16
04:04PM  Real Reform Has Yet to Be Seen, as Recovery Lags Behind
02:40PM  Friday links: bought by sheep
02:06PM  Bill Gross: Central Bankers Have Mastered the Art of Market Manipulation
10:05AM  Rubenstein Thinks That the Fed Will Hike the Rate in December
08:45AM  Why the stock market is stuck in a rut and how you can get out of it at MarketWatch
08:06AM  David Rubenstein: Why US Business Investment Is Declining
12:48AM  This Sentiment Reading Is Not Like The Others
Sep-08-16 12:04PM  Cooperman on the Hedge Fund Industry: Which Strategy Will Do Better?
11:21AM  5 ETFs to Help You Build Retirement Wealth at Motley Fool
09:59AM  Why Leon Cooperman Thinks Interest Rate Normalization Is Required
Sep-07-16 11:05AM  Key ADP Report Highlights: 177,000 New Jobs in August
08:05AM  Will the August Jobs Report Soften the Feds Rate Hike Urgency?
Sep-06-16 04:27PM  CASH: The Most Hated Asset Class On The Planet
02:30PM  Extremely Rare Volatility Signal Says A Big S&P 500 Move May Be Coming
12:43PM  Nasdaq nails major support, S&P 500 holds the range at MarketWatch
09:09AM  Status Quo for Dow, Nasdaq, S&P Means Unchanged ETFs
Sep-03-16 12:13PM  The Week Ahead: A September Smack Down For Investors? at Forbes
08:00AM  What to expect from the stock market this week
Sep-02-16 06:00PM  Stocks Jump as Odds of a Rate Hike Fall (SPY, DIA) at Investopedia
04:31PM  Stock Market Technical Analysis 9/2/16
11:32AM  Day after Labor Day Bullish
Sep-01-16 04:45PM  September jobs report day: Disappointment prone, but S&P 500 up 6 of last 8
02:52PM  How The Corporate Buyback Binge Blew Another Financial Bubble
09:11AM  An Appealing Market
Aug-31-16 07:04PM  Has Investor Sentiment Turned in Favor of Emerging Markets?
04:43PM  Trading before Labor Day Mixed
04:19PM  Stock Market Video Analysis 8/31/16
04:13PM  Small-Cap Stocks, ETFs Can Still Perform if Interest Rates Rise
11:54AM  There is Another Way to a Higher PnL
10:04AM  Jackson Hole: Yellen on the Feds Monetary Policy Framework Tools
08:53AM  How Stronger Economic Indicators Fueled Rate Hike Speculation
08:04AM  Did the US GDPs Meager 1.1% Rise in 2Q Meet Market Expectations?
Aug-30-16 04:38PM  Market Lacks Momentum and Bears
02:04PM  Why the Flash US Services PMI Remained Subdued in August
12:19PM  Bull trend intact, U.S. benchmarks absorb Fed-related volatility at MarketWatch
12:04PM  How Does the US August Manufacturing PMI Look?
11:24AM  361 Capital Weekly Research Briefing: It looks like a hike...
11:13AM  History Rhymes At Rydex
Aug-29-16 01:04PM  Capturing Gains Within The Context Of Normal Market Volatility
Aug-27-16 04:46PM  Weekend Market Video: 8-27-16
11:21AM  The Week Ahead: Should Investors Tune In Or Tune Out? at Forbes
08:00AM  What to expect from the stock market this week
Aug-26-16 06:42PM  Stocks Tread Water After Yellen Remarks (SPY, DIA) at Investopedia
06:05PM  Is Dow Theory Telling Us The Stock Rally Is Going To Fail?
04:44PM  Mixed Stock Market Messages
03:19PM  How Did Sanderson Farms Perform in 3Q16?
10:39AM  The Short Vol Trade Has Gotten Completely Out Of Hand
08:45AM  How to Trade Global Stock Market Volatility Since the Flash Crash
The investment seeks to track the investment results of the Russell 2000 Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
DHR Danaher Corp. daily Stock Chart
DHR [NYSE]
Danaher Corp.
IndexS&P 500 P/E19.51 EPS (ttm)3.93 Insider Own0.20% Shs Outstand690.54M Perf Week-0.27%
Market Cap52.90B Forward P/E19.66 EPS next Y3.90 Insider Trans-21.91% Shs Float606.06M Perf Month-4.87%
Income2.74B PEG2.50 EPS next Q0.82 Inst Own77.80% Short Float1.46% Perf Quarter3.82%
Sales22.08B P/S2.40 EPS this Y3.30% Inst Trans-0.90% Short Ratio2.49 Perf Half Y6.24%
Book/sh36.25 P/B2.11 EPS next Y9.50% ROA7.10% Target Price87.50 Perf Year19.22%
Cash/sh5.93 P/C12.91 EPS next 5Y7.80% ROE14.60% 52W Range61.40 - 82.64 Perf YTD9.14%
Dividend0.50 P/FCF16.88 EPS past 5Y7.70% ROI7.50% 52W High-7.31% Beta1.13
Dividend %0.65% Quick Ratio1.10 Sales past 5Y10.40% Gross Margin52.80% 52W Low24.76% ATR0.91
Employees81000 Current Ratio1.40 Sales Q/Q16.60% Oper. Margin16.70% RSI (14)34.50 Volatility0.97% 1.24%
OptionableYes Debt/Eq0.59 EPS Q/Q-5.50% Profit Margin15.90% Rel Volume0.90 Prev Close77.59
ShortableYes LT Debt/Eq0.48 EarningsOct 24 BMO Payout11.60% Avg Volume3.56M Price76.60
Recom1.80 SMA20-2.69% SMA50-4.41% SMA2004.49% Volume3,190,362 Change-1.28%
Jul-11-16Reiterated Barclays Overweight $105 → $86
Jul-05-16Initiated Goldman Neutral
Jun-24-16Upgrade Bernstein Mkt Perform → Outperform
May-27-16Reiterated RBC Capital Mkts Sector Perform $96 → $99
Apr-22-16Reiterated Stifel Buy $109 → $110
Apr-22-16Reiterated RBC Capital Mkts Sector Perform $87 → $96
Apr-22-16Reiterated Barclays Overweight $104 → $105
Apr-18-16Reiterated Barclays Overweight $99 → $104
Apr-04-16Downgrade Bernstein Outperform → Mkt Perform
Jan-27-16Reiterated RBC Capital Mkts Sector Perform $93 → $87
Dec-08-15Downgrade Goldman Buy → Neutral
Oct-26-15Reiterated Argus Buy $98 → $104
Oct-23-15Reiterated Stifel Buy $98 → $103
Oct-23-15Reiterated RBC Capital Mkts Sector Perform $91 → $92
Oct-23-15Reiterated Barclays Overweight $89 → $94
Oct-01-15Reiterated Stifel Buy $100 → $98
Sep-30-15Initiated Leerink Partners Outperform
Sep-09-15Reiterated RBC Capital Mkts Sector Perform $93 → $91
Sep-09-15Initiated Sterne Agee CRT Neutral
Jul-28-15Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-26-16 01:34PM  Proxy Statement Shows Danaher Faced Competition In Bid To Buy Cepheid
Sep-20-16 04:15PM  Danaher Schedules Third Quarter 2016 Earnings Conference Call PR Newswire
Sep-19-16 08:27AM  [$$] Serial acquirers: fools not suffered at Financial Times
Sep-16-16 12:58PM  Why GenMark Diagnostics, Inc. Is Soaring Today at Motley Fool
Sep-13-16 04:15PM  Danaher Announces Quarterly Dividend PR Newswire
Sep-12-16 10:21AM  Cepheid (CPHD) Stock Downgraded to 'Neutral' at Baird at TheStreet
Sep-09-16 01:27PM  JPMorgan: The Honeywell Bears Have Got It Wrong at Barrons.com
Sep-08-16 04:30PM  Danaher To Present At Morgan Stanley Laguna Conference PR Newswire
10:56AM  Danaher Corp. Value Analysis (NYSE:DHR) : September 8, 2016
09:45AM  Argus Starts Coverage On Danaher-Spinoff Fortive At Hold
09:30AM  The Zacks Analyst Blog Highlights: Verizon, EOG Resources, Danaher and Spectra Energy
08:07AM  Will Cepheid's (CPHD) Buyout by Danaher be a Strategic Fit?
Sep-07-16 06:04PM  How Cepheid Fits Strategically into DHRs Portfolio
04:04PM  DHR to Reap $200 Million in Cost Synergies, Revenue through Buy
02:23PM  What Made Cepheid Attractive to Danaher?
01:57PM  Cepheid (CPHD) Stock Price Target Raised at Barclays on Danaher Deal at TheStreet
12:56PM  Top Research Reports for September 7, 2016
11:22AM  BTIG Sees Another Bidder For Cepheid 'Unlikely'
10:06AM  Stock Market News for September 07, 2016
09:17AM  Blog Coverage Danaher Strengthens its Diagnostics Business with Cepheid Acquisition
09:15AM  Blog Coverage Danaher Strengthens its Diagnostics Business with Cepheid Acquisition Accesswire
08:40AM  Danaher Corp. breached its 50 day moving average in a Bearish Manner : DHR-US : September 7, 2016
08:11AM  Danaher to Buy Cepheid for $4B in First Deal Post Spinoff
12:05AM  Business Watch at The Wall Street Journal
Sep-06-16 04:49PM  Danaher Buying Cepheid To Expand Diagnostics Business
04:05PM  Stocks See Slight Gains as September Rate Hike Chances Shrink
03:17PM  Cepheid Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Cepheid PR Newswire
03:01PM  Takeover Tuesday: Deals driving the action
02:50PM  Danaher buys up diagnostics company Cepheid for $4 billion at bizjournals.com
02:38PM  Does Danahers Cepheid Deal Have More Sizzle Than Meets the Eye? at 24/7 Wall St.
01:00PM  Danaher's New Look Is Pricey to Maintain at Bloomberg
11:56AM  Why Cepheid Is Skyrocketing Today at Motley Fool
11:47AM  Cepheid (CPHD) Stock Surges, to be Acquired by Danaher for $4 Billion at TheStreet
11:39AM  Danaher to buy Cepheid in $4 bln deal to expand in diagnostics Reuters
11:10AM  Danaher Corporation -- Moody's: Danaher's A2 rating unaffected by planned acquisition of Cepheid for $4 billion at Moody's
10:51AM  Danaher: Cepheid Acquisition Too 'Ho Hum' For Own Good? at Barrons.com
10:12AM  Stocks Erase Gains; Navistar, Cepheid Spike On Deal News
09:50AM  Why These Stocks Are in Spotlight Today at Insider Monkey
09:47AM  No September Rate Hike, Yes to More M&A: DHR, CPHD, GE, BAYRY, MON
09:34AM  Wall Street Returns From Long Weekend With Slight Gains as Fed Stays in Crosshairs
08:40AM  Danaher to buy Cepheid for $4B
08:01AM  Stock Futures Creep Higher; Navistar, Cephid Spike On Deal News
07:52AM  [$$] Danaher to Buy Diagnostics Company Cepheid for $4 Billion at The Wall Street Journal
07:46AM  Here's a quick guide to what traders are talking about right now
07:46AM  CEPHEID (CPHD) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Cepheid; Are Shareholders Getting a Fair Price? PR Newswire
07:17AM  Danaher Bolsters Diagnostics Business with Cepheid Purchase
07:13AM  Danaher to buy diagnostics maker Cepheid for about $4 billion at MarketWatch
06:57AM  Danaher buying Cepheid in deal valued at about $4 billion AP
06:40AM  Danaher Agrees to Buy Cepheid in a Deal Valued at $4 Billion at Bloomberg
06:39AM  Danaher to buy Cepheid for about $4 bln, including debt Reuters
06:30AM  Danaher To Acquire Cepheid For $53.00 Per Share, Or Approximately $4 Billion PR Newswire
06:30AM  Cepheid Agrees To Be Acquired By Danaher Corporation For $53 Per Share In Cash PR Newswire
Sep-02-16 03:52PM  Looking For Winners? Here Are Hot Stocks Driving The Hottest Sectors Post-Brexit
Aug-30-16 03:52PM  Danaher's Reversal May Be More Important Than Its All-Time High
11:07AM  ETFs with exposure to Danaher Corp. : August 30, 2016
Aug-29-16 12:27PM  Five Capital Goods Stocks to Buy Now at Insider Monkey
Aug-23-16 01:31PM  Numerous Companies Reach 52-Week Highs
06:00AM  Danaher to Present At Vertical Research Partners Industrial Conference PR Newswire
Aug-19-16 01:42PM  Make 'Defensive' General Electric Part of a 'Barbell Strategy' in Industrials? at Barrons.com
01:00PM  Heres Why You Should Look for Dividendsand How
Aug-18-16 12:22PM  Chuck Akre Buys Fortive, Sells Arlington
Aug-16-16 12:13PM  ETFs with exposure to Danaher Corp. : August 16, 2016
Aug-15-16 01:00PM  Real Estate Stocks Dominate Tricadia Capitals Top-5 Holdings at Insider Monkey
Aug-10-16 11:04AM  Parker-Hannifins 2017 Guidance Suggests Slowdown in Industrials
Aug-08-16 03:53PM  Ecolab Declares Dividend of $0.35 Per Share
Aug-04-16 04:10PM  Citigroup Upgrades Ecolabs Rating to Buy
02:49PM  ETFs with exposure to Danaher Corp. : August 4, 2016
Aug-02-16 11:45AM  Danaher Corp. :DHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 2, 2016
Jul-29-16 11:06AM  Why Roper Technologies 1H16 Operating Cash Flows Declined
Jul-28-16 02:50PM  [$$] Cray, NetScout Ready to Rise at Barrons.com
01:04PM  DANAHER CORP /DE/ Financials
Jul-26-16 03:31PM  Dovers Earnings Plummet on Low Energy Earnings
11:48AM  How Do We Deal With This Stabilization?
Jul-25-16 02:51PM  [$$] Danaher Earnings Top Views at The Wall Street Journal
01:07PM  Edited Transcript of DHR earnings conference call or presentation 25-Jul-16 12:00pm GMT
10:36AM  Why Traders Are Watching Tesla, SolarCity, Allergan & Other Stocks Today at Insider Monkey
10:01AM  U.S. stocks retreat from records as investors sift earnings deluge at MarketWatch
10:00AM  Danaher (DHR) Beats on Q2 Earnings, Guidance Lowered
09:05AM  Danaher (DHR) Stock Gains on Q2 Earnings Beat
07:51AM  Danaher Delivers Better Than Expected Q2 Earnings
07:45AM  Danaher (DHR) Beats Q2 Earnings, Lags Revenues
07:07AM  Q2 2016 Danaher Corp Earnings Release - 06:00 am ET
06:16AM  DANAHER CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Financ
06:11AM  DANAHER CORP /DE/ Files SEC form 10-Q, Quarterly Report
06:09AM  Danaher beats 2Q profit forecasts
06:01AM  Danaher Reports Second Quarter 2016 Results PR Newswire
Jul-22-16 06:17PM  Cramers earnings approach: Buy at the end of the week, not the beginning at CNBC
02:48PM  Danaher (DHR) Stock Slips Ahead of Q2 Earnings Report
10:19AM  2 Conglomerates' Earnings to Watch on Jul 25: DHR, CR
09:16AM  Danaher attracts another upside position
Jul-21-16 01:47PM  Danaher Corporation -- Moody's affirms A2 unsecured rating of Danaher; outlook to stable at Moody's
08:24AM  Danaher (DHR) Q2 Earnings: Stock Likely to Disappoint?
Jul-19-16 12:17PM  ETFs with exposure to Danaher Corp. : July 19, 2016
Jul-18-16 07:27PM  Cramer: This battleground stock defies current wisdom at CNBC
05:05PM  With Danaher Spinoff Transaction Complete, Trifecta Stocks Exit Position With Profit
12:12PM  Ecolab Invests in Aquatech International to Improve Processes
Jul-15-16 03:51PM  Danaher To Redeem Senior Notes
11:01AM  [$$] Top Picks in Financial Technology at Barrons.com
09:29AM  Danaher Corporation To Redeem Senior Notes PR Newswire
08:50AM  What Falling Estimates & Price Mean for Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Its Test & Measurement segment provides instruments products; services and products that help to convert concepts into finished products; professional tools; and wheel service equipment. The company's Environmental segment provides instrumentation and disinfection systems; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale and payment system, environmental compliance, vehicle tracking, and fleet management. Its Life Sciences & Diagnostics segment offers chemistry systems, immunoassay systems, hematology and flow cytometry products, microbiology systems, and systems and workflow automations solutions. This segment also provides professional microscopes; mass spectrometers; bioanalytical measurement systems; workflow instruments and consumables; and filtration products, which are used to remove solid, liquid, and gaseous contaminants. The company's Dental segment offers consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. The company's Industrial Technologies segment provides equipment, consumables, and software for various printing, marking, coding, packaging, design, and color management applications; and a range of electromechanical and electronic motion control products. This segment also offers devices that sense, monitor and control operational or manufacturing variables; instruments, controls, and monitoring systems used in electric utilities and industrial facilities; engineered energetic materials components; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Joyce Thomas Patrick JRPresident and CEOAug 01Option Exercise28.5536,1251,031,369205,407Aug 02 06:07 PM
Joyce Thomas Patrick JRPresident and CEOAug 01Sale81.4445,8973,737,980169,282Aug 02 06:07 PM
COMAS DANIEL LEVP & CFOJul 27Option Exercise22.2696,4462,147,333259,270Jul 29 07:56 AM
COMAS DANIEL LEVP & CFOJul 27Sale80.8896,4467,800,332189,270Jul 29 07:56 AM
HEFNER LINDA PDirectorJul 11Option Exercise23.8810,578252,60320,197Jul 12 04:54 PM
Lalor Angela SSVP, Human ResourcesMay 12Sale97.778,392820,46148,110May 13 08:41 AM
SCHWIETERS JOHN TDirectorMay 06Option Exercise31.578,000252,56026,958May 09 05:36 PM
LICO JAMES AExecutive Vice PresidentApr 27Option Exercise37.7540,0001,510,000181,517Apr 29 07:27 AM
LICO JAMES AExecutive Vice PresidentApr 27Sale96.9358,9545,714,495122,563Apr 29 07:27 AM
Raskas DanielSVP-Corporate DevelopmentApr 22Option Exercise37.0724,300900,80141,524Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Option Exercise37.7589,2803,370,320230,978Apr 26 05:04 PM
DANIEL WILLIAM KEVPApr 22Option Exercise39.8226,1401,040,895164,785Apr 26 05:03 PM
Joyce Thomas Patrick JRPresident and CEOApr 22Sale95.5014,6301,397,165137,246Apr 26 05:04 PM
King WilliamSenior Vice PresidentApr 22Sale96.316,000577,86017,386Apr 26 05:02 PM
Raskas DanielSVP-Corporate DevelopmentApr 22Sale95.9524,3002,331,58517,224Apr 26 05:03 PM
DANIEL WILLIAM KEVPApr 22Sale96.0641,1403,952,086123,645Apr 26 05:03 PM
COMAS DANIEL LEVP & CFOApr 22Sale95.7189,2808,545,015141,698Apr 26 05:04 PM
LICO JAMES AExecutive Vice PresidentFeb 29Option Exercise37.2460,0002,234,155186,878Mar 01 05:56 PM
LICO JAMES AExecutive Vice PresidentFeb 29Sale89.2460,0005,354,348141,517Mar 01 05:56 PM
LOHR WALTER GDirectorFeb 26Option Exercise31.578,000252,560461,505Feb 29 05:48 PM
Raskas DanielSVP-Corporate DevelopmentFeb 26Sale89.004,656414,38417,786Feb 29 05:48 PM
LOHR WALTER GDirectorFeb 26Sale89.068,000712,440453,505Feb 29 05:48 PM
EHRLICH DONALD JDirectorFeb 10Option Exercise31.578,000252,56077,905Feb 11 05:46 PM
EHRLICH DONALD JDirectorFeb 10Sale86.008,000688,00069,905Feb 11 05:46 PM
Joyce Thomas Patrick JRPresident and CEOJan 27Option Exercise37.0725,300937,871141,123Jan 28 05:51 PM
Joyce Thomas Patrick JRPresident and CEOJan 27Sale83.9825,3002,124,654115,823Jan 28 05:51 PM
LICO JAMES AExecutive Vice PresidentNov 24Option Exercise37.0755,8402,069,989191,245Nov 25 09:02 AM
LICO JAMES AExecutive Vice PresidentNov 24Sale96.4055,8405,382,808135,405Nov 25 09:02 AM
DANIEL WILLIAM KEVPOct 30Option Exercise37.7539,7401,500,185137,690Nov 02 06:18 PM
DANIEL WILLIAM KEVPOct 30Sale93.0439,7403,697,50997,950Nov 02 06:18 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 23Option Exercise37.0726,400978,64842,492Oct 26 05:53 PM
Joyce Thomas Patrick JRPresident and CEOOct 23Option Exercise37.0725,300937,871141,123Oct 26 05:53 PM
COMAS DANIEL LEVP & CFOOct 23Option Exercise37.0736,2001,341,934135,998Oct 26 05:54 PM
COMAS DANIEL LEVP & CFOOct 23Sale92.7136,2003,356,10299,798Oct 26 05:54 PM
Joyce Thomas Patrick JRPresident and CEOOct 23Sale93.4725,3002,364,892115,823Oct 26 05:53 PM
LUTZ ROBERT SSVP-Chief Accounting OfficerOct 23Sale93.4526,4002,467,02716,092Oct 26 05:53 PM
WY Weyerhaeuser Co. daily Stock Chart
WY [NYSE]
Weyerhaeuser Co.
IndexS&P 500 P/E45.72 EPS (ttm)0.69 Insider Own0.20% Shs Outstand748.73M Perf Week5.01%
Market Cap23.69B Forward P/E26.45 EPS next Y1.20 Insider Trans-32.11% Shs Float740.45M Perf Month1.29%
Income408.00M PEG9.14 EPS next Q0.21 Inst Own77.80% Short Float1.89% Perf Quarter19.34%
Sales6.61B P/S3.58 EPS this Y-36.40% Inst Trans-2.15% Short Ratio3.27 Perf Half Y3.99%
Book/sh12.67 P/B2.50 EPS next Y47.65% ROA2.70% Target Price35.12 Perf Year21.29%
Cash/sh0.65 P/C48.84 EPS next 5Y5.00% ROE6.30% 52W Range21.38 - 32.85 Perf YTD8.87%
Dividend1.24 P/FCF- EPS past 5Y-25.80% ROI9.10% 52W High-3.68% Beta1.37
Dividend %3.92% Quick Ratio1.90 Sales past 5Y3.50% Gross Margin21.70% 52W Low47.96% ATR0.69
Employees12600 Current Ratio2.10 Sales Q/Q23.00% Oper. Margin13.40% RSI (14)54.82 Volatility2.30% 2.07%
OptionableYes Debt/Eq0.99 EPS Q/Q-27.40% Profit Margin7.00% Rel Volume0.58 Prev Close32.18
ShortableYes LT Debt/Eq0.99 EarningsOct 28 BMO Payout160.10% Avg Volume4.29M Price31.64
Recom2.10 SMA202.13% SMA500.47% SMA2008.33% Volume2,476,152 Change-1.68%
Sep-22-16Initiated Goldman Buy $37
Aug-12-16Downgrade Dundee Buy → Neutral
Aug-08-16Downgrade DA Davidson Buy → Neutral $33
Jun-29-16Upgrade DA Davidson Neutral → Buy
May-09-16Downgrade DA Davidson Buy → Neutral $34 → $33
Feb-17-16Reiterated Argus Buy $43 → $28
Jan-19-16Upgrade Dundee Neutral → Buy
Nov-17-15Reiterated RBC Capital Mkts Outperform $37 → $35
Nov-13-15Upgrade Credit Agricole Underperform → Outperform
Sep-15-15Upgrade BofA/Merrill Neutral → Buy
Jul-16-15Downgrade BofA/Merrill Buy → Neutral
Jun-17-15Initiated Dundee Neutral $34
May-04-15Reiterated UBS Sell $29 → $27
Feb-17-15Reiterated Argus Buy $39 → $43
Nov-03-14Reiterated DA Davidson Buy $37 → $40
Aug-18-14Reiterated Argus Buy $36 → $39
Aug-04-14Upgrade DA Davidson Neutral → Buy $33 → $37
Apr-29-13Reiterated UBS Sell $20 → $24
Jan-29-13Reiterated Argus Buy $33 → $36
Jan-28-13Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $31
Sep-23-16 08:58AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : September 23, 2016
Sep-22-16 04:13PM  The Hot Stock: Weyerhaeuser Gains 5.7% Because That's the Power of Goldman Sachs at Barrons.com +5.74%
01:57PM  Reaction to Weyerhaeuser (WY) 'Buy' Rating at Goldman
12:35PM  Call of the day: Weyerhaeuser & SeaWorld
12:30PM  Goldman Neutral On Paper/Forest Products: Prefers Boise Cascade, Weyerhauser
08:55AM  Weyerhaeuser (WY) Stock Climbs, Gets 'Buy' Rating at Goldman
07:57AM  Early movers: AZO, RAD, CBS, SEAS, BBBY, YHOO, WCIC, JBL, RHT, LMT & more at CNBC
06:42AM  Coverage initiated on Weyerhaeuser by Goldman
Sep-21-16 07:19PM  Cramer: Don't sweat it, this stock goes to $200 in the long run at CNBC
Sep-20-16 10:43AM  Strong Housing Starts And Chinese Demand Bode Well For Weyerhaeuser
Sep-01-16 10:13AM  Top Research Reports for 1st September, 2016
10:10AM  Stock Market News for September 01, 2016
06:46AM  Weyerhaeuser (WY) Sells Liquid Packaging Facility to Nippon
Aug-31-16 04:30PM  Weyerhaeuser Completes Sale of Liquid Packaging Board Business to Nippon Paper Industries PR Newswire
Aug-30-16 11:50AM  These Seemingly Boring Investments Can Generate Exciting Returns
Aug-29-16 12:13PM  ETFs with exposure to Weyerhaeuser Co. : August 29, 2016
Aug-26-16 08:07AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : August 26, 2016
Aug-25-16 01:04PM  WEYERHAEUSER CO Financials
Aug-24-16 04:30PM  Weyerhaeuser to present at RBC Global Industrials Conference PR Newswire
Aug-22-16 04:31PM  WEYERHAEUSER CO Files SEC form 8-K, Amendment or Waiver to Code of Ethics, Financial Statements and Exhibits
Aug-19-16 04:30PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
Aug-18-16 06:00PM  Chill out, man: Burien is getting a big cold storage warehouse, too at bizjournals.com
Aug-16-16 04:45PM  Weyerhaeuser to hold Investor Meeting on Dec. 13 PR Newswire
Aug-14-16 01:35PM  First Eagle Investment Has A Material Fondness for These 5 Materials Stocks at Insider Monkey
Aug-13-16 05:34PM  Five REITs Billionaires Are Fond Of at Insider Monkey
Aug-11-16 01:19PM  ETFs with exposure to Weyerhaeuser Co. : August 11, 2016
Aug-10-16 03:54PM  International Paper: Takeover Time? at Barrons.com
09:42AM  Post Earnings Coverage as Weyerhaeuser Logs Double Digit Growth on Top and Bottomline
09:15AM  Post Earnings Coverage as Weyerhaeuser Logs Double Digit Growth on Top and Bottomline Accesswire
Aug-09-16 10:37AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016
Aug-08-16 10:22AM  Weyerhaeuser (WY) Stock Rating Downgraded at Davidson
10:10AM  Company News for August 08, 2016
07:30AM  Building Trades for Weyerhaeuser
Aug-05-16 02:55PM  Edited Transcript of WY earnings conference call or presentation 5-Aug-16 2:00pm GMT
11:00AM  Here's Why Weyerhaeuser Belongs in Your Portfolio
08:12AM  Weyerhaeuser (WY) Stock Advances on Raised 2H Guidance
08:03AM  Weyerhaeuser (WY) Lags Q2 Earnings, Revises Segments
08:02AM  Early movers: COH, CTSH, WLTW, PCLN, LNKD, ATVI, KHC, RAX & more at CNBC
07:07AM  Q2 2016 Weyerhaeuser Co Earnings Release - Before Market Open
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:02AM  Weyerhaeuser misses Street 2Q forecasts
03:05AM  Weyerhaeuser Reports Second Quarter Results PR Newswire
Aug-04-16 01:50PM  How Will Weyerhaeuser (WY) Stock React to Friday's Q2 Earnings?
10:35AM  Construction Stocks' Q2 Earnings Slated for Aug 5: WY, IBP
Aug-03-16 11:35AM  Bourgeon Capital Management Reveals Top Picks for Q3, With JPMorgan Chase & Co. (JPM) Leading the Pack at Insider Monkey
08:31AM  Weyerhaeuser (WY) to Report Q2 Earnings: What to Expect?
Aug-02-16 09:41AM  International Paper Company -- Moody's rates International Paper's new senior unsecured notes Baa2 at Moody's
Jul-28-16 06:03PM  [$$] International Paper Sees Weak Packaging Demand In Brazil Before Olympics at The Wall Street Journal
Jul-27-16 08:10AM  Paper Stocks Reporting Q2 Earnings on Jul 28: IP & MERC
Jul-18-16 03:46PM  The Best REITs Right Now for Returns, Dividends at Investopedia
Jul-15-16 02:01PM  3 Stocks to Buy With Dividends Yielding More Than 4% at Motley Fool
Jul-11-16 09:08AM  Weyerhaeuser Co. breached its 50 day moving average in a Bullish Manner : WY-US : July 11, 2016
Jul-10-16 12:00PM  3 Stocks That Pay You to Own Them at Motley Fool
Jul-08-16 10:10AM  Bear of the Day: Weyerhaeuser (WY)
Jul-07-16 08:13AM  Weyerhaeuser (WY) Now a Strong Sell On Gloomy Prospects
Jul-06-16 04:30PM  Weyerhaeuser to release second quarter results on August 5 PR Newswire
Jul-01-16 12:23PM  Third Avenue Management Buys 6 Stocks in Second Quarter
Jun-30-16 07:01AM  Weyerhaeuser to Turn Preference Shares to Common Shares
Jun-29-16 04:20PM  Weyerhaeuser announces conversion of Mandatory Convertible Preference Shares PR Newswire
04:11PM  Weyerhaeuser stock pops, D.A. Davidson calls it 'best in class' at CNBC
09:33AM  Weyerhaeuser (WY) Stock Climbs After D.A. Davidson Upgrade
Jun-28-16 06:04PM  Developer plans 620 apartments on Minneapolis-St. Paul border at bizjournals.com
Jun-24-16 05:35PM  Seattle-area stocks: Brexit news punishes Tableau, Juno, Paccar in Friday trading at bizjournals.com -6.06%
Jun-23-16 07:47AM  Weyerhaeuser to Close Lumber and Plywood Mill in Montana
Jun-22-16 05:30PM  Weyerhaeuser to close Columbia Falls lumber mill and plywood mill PR Newswire
Jun-20-16 01:19PM  2 Lesser-Known Dividend Stocks to Buy During Times of Extreme Volatility
Jun-18-16 12:01AM  [$$] Canaccord Sees Strategic Fit In Microsoft-LinkedIn Hookup at Barrons.com
Jun-17-16 01:31PM  Weyerhaeuser attracts show of support
01:15PM  International Paper Company -- Moody's assigns Prime-2 short term rating to International Paper Company at Moody's
Jun-16-16 04:23PM  Weyerhaeuser Presses on with Printing Paper Sale After Nippon Deal
07:40AM  Weyerhaeuser to Sell Liquid Packaging Facility to Nippon
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Other Events
Jun-15-16 11:25PM  Weyerhaeuser sells final piece of cellulose fibers business at bizjournals.com
08:00PM  Weyerhaeuser to sell Liquid Packaging Board business to Nippon Paper Industries for $285 million in cash PR Newswire
10:37AM  3 Dividend Growers Rallying Up Summer's Wall Of Worry at Forbes
Jun-08-16 08:06AM  Weyerhaeuser Stock To Trade Ex-Dividend Wednesday (WY) at Investopedia
Jun-03-16 03:50PM  ETFs with exposure to Weyerhaeuser Co. : June 3, 2016
May-31-16 09:55AM  5 Dividend Stocks to Buy in June at Motley Fool
May-25-16 06:01AM  WEYERHAEUSER CO Files SEC form 8-K, Change in Directors or Principal Officers
May-23-16 12:08PM  Tri Pointe Homes, Inc. -- Moody's Assigns B1 to TRI Pointe's New Senior Notes; Affirms All Ratings; Outlook Positive at Moody's
May-20-16 04:55PM  Weyerhaeuser Company declares dividend on common shares PR Newswire
08:58AM  What Makes Weyerhaeuser Company (WY) A Strong Sell?
May-19-16 08:45AM  New Strong Sell Stocks for May 19th
May-18-16 09:09AM  Weyerhaeuser Co. breached its 50 day moving average in a Bearish Manner : WY-US : May 18, 2016
May-17-16 05:07PM  Common And Deadly Investing Mistakes: Buys On The Way Down
05:07PM  Common And Deadly Investing Mistakes: Buys On The Way Down at Investor's Business Daily
May-16-16 01:05AM  Why Ingersoll Rands Net Debt Increased in 1Q16
May-15-16 03:10AM  Third Avenue Management Cuts Real Estate Holdings Heading Into Q2 at Insider Monkey
May-14-16 04:16PM  First Eagle Investment Managements Top Stock Picks This Quarter; Oracle Corp Leads the Pack at Insider Monkey
May-12-16 03:11PM  ETFs with exposure to Weyerhaeuser Co. : May 12, 2016
May-11-16 10:21AM  Weyerhaeuser Co. :WY-US: Earnings Analysis: Q1, 2016 By the Numbers
May-09-16 04:25PM  Tesla Gets Bullish Report; 2 Recent Medical IPOs Rated As Buys
04:25PM  Tesla Gets Bullish Report; 2 Recent Medical IPOs Rated As Buys at Investor's Business Daily
May-06-16 10:04PM  Edited Transcript of WY earnings conference call or presentation 6-May-16 2:00pm GMT Thomson Reuters StreetEvents
08:16AM  Weyerhaeuser (WY) Beats on Q1 Earnings, Revenues Lag Zacks
07:55AM  Early movers: CI, ICE, SQ, ATVI, YELP, HON, WYNN, GPRO, HLF & more at CNBC
07:07AM  Q1 2016 Weyerhaeuser Co Earnings Release - Before Market Open CCBN
06:02AM  WEYERHAEUSER CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
05:03AM  Weyerhaeuser beats 1Q profit forecasts AP
03:05AM  Weyerhaeuser Reports First Quarter Results PR Newswire
Weyerhaeuser Co. is a real estate investment trust. It primarily invests in United States. The firm operates under four business segments, timberlands, wood products, cellulose fibers and real estate. It owns timberlands primarily in the U.S and has long-term licenses in Canada. The firm manufactures wood and specialty cellulose fibers products, and develops real estate, primarily as a builder of single-family homes. Weyerhaeuser Co was founded in 1900 and is based in Federal Way, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slater Catherine ISenior Vice PresidentAug 12Sale31.8111,609369,29470,466Aug 16 03:14 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Option Exercise16.8059,6861,002,921110,432Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 10Sale32.5859,6861,944,52850,746Aug 11 07:31 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Option Exercise9.534,49242,80055,238Aug 10 08:28 PM
HILLMAN JEANNE MVP & Chief Accounting OfficerAug 09Sale32.504,492145,99050,746Aug 10 08:28 PM
Hunter Rhonda DSr. Vice PresidentJul 27Option Exercise23.563,31878,16261,768Jul 27 09:06 PM
Hunter Rhonda DSr. Vice PresidentJul 27Sale33.003,318109,49458,450Jul 27 09:06 PM
HOLLEY RICK RDirectorJul 26Option Exercise24.11181,0434,364,595735,113Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 26Sale32.64181,0435,909,092554,070Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Option Exercise24.41426,95710,423,885981,027Jul 27 06:46 PM
HOLLEY RICK RDirectorJul 25Sale32.51426,95713,881,368554,070Jul 27 06:46 PM
Hunter Rhonda DSr. Vice PresidentJun 30Option Exercise20.423,29267,22361,742Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 30Sale30.003,29298,76058,450Jul 01 08:44 PM
Hunter Rhonda DSr. Vice PresidentJun 20Sale29.126,500189,28058,019Jun 22 03:35 PM
Bozeman David PDirectorJun 09Sale30.301,92958,4566,262Jun 13 12:42 PM
Emmert Mark ADirectorJun 07Sale31.259,536298,0009,715Jun 08 07:56 PM
Merle Denise MSenior Vice PresidentDec 17Sale30.742,58079,31019,990Dec 21 01:57 PM
Bedient Patricia MExecutive Vice President & CFONov 19Option Exercise26.2718,581488,104210,982Nov 20 07:07 PM
Bedient Patricia MExecutive Vice President & CFONov 19Sale32.0018,581594,592192,401Nov 20 07:07 PM
Slater Catherine ISenior Vice PresidentOct 22Option Exercise20.425,483111,93538,480Oct 23 06:38 PM
Hunter Rhonda DSr. Vice PresidentOct 22Option Exercise20.423,29167,18640,502Oct 23 06:48 PM
Hunter Rhonda DSr. Vice PresidentOct 22Sale30.003,29198,73037,211Oct 23 06:48 PM
Slater Catherine ISenior Vice PresidentOct 22Sale30.005,483164,49032,997Oct 23 06:38 PM
Slater Catherine ISenior Vice PresidentOct 19Option Exercise14.803,56752,80240,433Oct 21 05:40 PM
Slater Catherine ISenior Vice PresidentOct 19Sale29.347,436218,17232,997Oct 21 05:40 PM
Hunter Rhonda DSr. Vice PresidentOct 19Sale29.344,567133,99637,211Oct 21 05:13 PM
CELG Celgene Corporation daily Stock Chart
CELG [NASD]
Celgene Corporation
IndexS&P 500 P/E44.63 EPS (ttm)2.38 Insider Own0.20% Shs Outstand775.11M Perf Week-1.32%
Market Cap82.40B Forward P/E15.20 EPS next Y6.99 Insider Trans-16.50% Shs Float773.04M Perf Month-1.48%
Income1.93B PEG2.04 EPS next Q1.48 Inst Own79.20% Short Float0.76% Perf Quarter12.08%
Sales10.16B P/S8.11 EPS this Y-18.80% Inst Trans-1.31% Short Ratio1.37 Perf Half Y6.15%
Book/sh7.15 P/B14.87 EPS next Y22.53% ROA7.20% Target Price137.30 Perf Year-1.92%
Cash/sh8.26 P/C12.87 EPS next 5Y21.87% ROE35.10% 52W Range93.05 - 128.39 Perf YTD-11.23%
Dividend- P/FCF27.85 EPS past 5Y15.70% ROI8.90% 52W High-17.20% Beta1.48
Dividend %- Quick Ratio4.40 Sales past 5Y20.60% Gross Margin95.70% 52W Low14.25% ATR2.26
Employees6971 Current Ratio4.60 Sales Q/Q20.90% Oper. Margin27.10% RSI (14)44.02 Volatility2.05% 1.96%
OptionableYes Debt/Eq0.00 EPS Q/Q72.90% Profit Margin18.90% Rel Volume0.97 Prev Close109.43
ShortableYes LT Debt/Eq2.58 EarningsOct 27 BMO Payout0.00% Avg Volume4.27M Price106.31
Recom1.80 SMA20-0.98% SMA50-2.91% SMA2000.57% Volume4,127,274 Change-2.85%
Jul-15-16Initiated Stifel Buy $138
Apr-29-16Reiterated Sun Trust Rbsn Humphrey Buy $145 → $147
Feb-25-16Initiated Citigroup Buy $130
Jan-20-16Initiated Credit Suisse Outperform
Jan-14-16Initiated Standpoint Research Buy $130
Jan-08-16Initiated Sun Trust Rbsn Humphrey Buy $145
Jan-07-16Initiated Sun Trust Rbsn Humphrey Buy
Nov-06-15Reiterated UBS Buy $156 → $145
Oct-01-15Upgrade JP Morgan Neutral → Overweight
Sep-09-15Initiated Jefferies Buy
Sep-01-15Initiated Raymond James Strong Buy $160
Jul-24-15Reiterated UBS Buy $142 → $156
Jul-24-15Reiterated JMP Securities Mkt Outperform $133 → $147
Jul-24-15Reiterated Cantor Fitzgerald Buy $146 → $163
Jul-21-15Reiterated Piper Jaffray Overweight $144 → $160
Jul-15-15Reiterated RBC Capital Mkts Outperform $135 → $150
Jul-15-15Reiterated Barclays Equal Weight $120 → $130
Feb-25-15Reiterated Argus Buy $130 → $155
Dec-09-14Reiterated UBS Buy $112 → $130
Dec-09-14Reiterated Argus Buy $102 → $130
Sep-26-16 04:25PM  3 Top Biotech Stocks to Buy on Sale at Motley Fool
11:04AM  Whats the Upside Potential for Gilead?
09:30AM  3 Health Stocks to Hold for the Next Decade at Kiplinger
08:51AM  Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : September 26, 2016
08:50AM  S&P 500 Stocks to Buy and Hold for the Next 10 Years at Kiplinger
Sep-23-16 11:10AM  The Factors behind Gileads Discounted Valuation
10:04AM  What Are Analysts Recommendations for Gilead Sciences?
06:25AM  Allergan's Vitae Buy Could Spark More Interest in Kadmon
Sep-22-16 10:45AM  HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target
Sep-21-16 03:46PM  The Most Exciting Drug in Celgene's Pipeline at Motley Fool
11:05AM  Ioniss Orphan Drug in Third Phase of Clinical Trials
08:04AM  Orphan Drug Designation among Latest Happenings at Ionis
Sep-20-16 11:04AM  Bristol-Myers Squibbs Role in the Multiple Myeloma Market
06:53AM  Celgene Presents Efficacy & Safety Phase II Ozanimod Data
Sep-19-16 06:56PM  How To Predict The Next Sarepta (FDA Approval Stock) And Win Big at Forbes
08:41AM  3 Top Stocks on Sale This Fall at Motley Fool
08:25AM  RBC Says These 4 Top Biotechs Could Have Big Upside Potential at 24/7 Wall St.
Sep-16-16 12:49PM  Vertex: Did Management Deliver Investors a Backhanded Slap? at Barrons.com
10:30AM  Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with Relapsing Multiple Sclerosis Presented at 32nd ECTRIMS Business Wire
Sep-15-16 11:50AM  Celgene Outspends Big Pharmas in Deals (CELG) at Investopedia
11:31AM  Celgenes Big Bet May Pay Off (CELG) at Investopedia
10:44AM  5 Reasons Celgene Is a Buy at Motley Fool
Sep-14-16 04:16PM  Biotechs Help Nasdaq To Small Gain; Apple's Rise Fails To Spur Dow
Sep-13-16 10:04AM  Biogen Committed to Bolstering Its Strong Product Pipeline
09:37AM  Celgene's Crohn's Disease Drug Positive in Phase Ib Study
07:30AM  First-Ever Psoriatic Arthritis Awareness Day Aims to Educate on Importance of Early Diagnosis and Treatment Business Wire
07:05AM  Short Sellers Run for Cover From Major Biotechs at 24/7 Wall St.
Sep-12-16 06:45PM  Traders pick biotech stocks as sector sees best day in months at CNBC
05:00PM  Buying biotech: 5 trades in pharma
03:32PM  Biotech: Four Catalysts for Four Stocks at Barrons.com
03:24PM  Response to Bloomberg Article on Celgene Payment: David Steensma at Bloomberg
11:59AM  Two Things You Must Understand About Biotech Investing at Motley Fool
11:48AM  Celgene Data Offer A Rorschach Test To Wall Street at Forbes
07:50AM  CELGENE CORP /DE/ Files SEC form 8-K, Other Events
07:30AM  Celgene Announces Interim Topline Data from Trial of Investigational Oral GED-0301 in Patients with Active Crohns Disease Business Wire
Sep-11-16 10:35AM  4 Key BioPharma Movers in the Past Week at 24/7 Wall St.
Sep-09-16 03:04PM  Market Watches to See if Biogen Will Meet Its Raised Guidance
11:04AM  Analysts Look for Celgene to Offer Striking Returns in 2016
10:24AM  3 Reasons bluebird bio, Inc. Stock Dipped 13.7% in August at Motley Fool
10:04AM  Global Expansion to Fuel Revenue for Otezla
09:14AM  10 Must-Know Biotech Stock Events to Close Out 2016
08:04AM  When Will the Generic Version of Abraxane Be Available?
Sep-08-16 02:53PM  Biogen: Be Like Celgene? at Barrons.com
11:04AM  Celgene Carves Out More Share of This Cancer Treatment Market
10:04AM  What Are the Possible Threats to Revlimid?
10:00AM  Celgene Corporation (Nasdaq: CELG) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
09:16AM  Blog Coverage Celgene Partner of Agios Pharma Plans NDA to Get FDA Approval for Blood Cancer Drug AG 221
09:09AM  Agios' (AGIO) Partner Celgene to File for Enasidenib, Stock Up
08:04AM  How Can Revlimid Eventually Lead the Lymphoma Space?
Sep-07-16 04:40PM  Agios Stock Soars As Partner Celgene Preps Drug Filing
03:11PM  Celgene Shows Spending Pays at Bloomberg
03:04PM  This Celgene Cancer Treatment Could Lead the Industry by 2021
02:04PM  Celgenes Enterprise Value to Earnings in Line with Peers
01:45PM  Why Agios Pharmaceuticals Inc Stock Skyrocketed Today at Motley Fool
12:10PM  Did Agios Just Speed Up Its Business Plan by 2 Years? at 24/7 Wall St.
11:41AM  Understanding Celgenes Premium PE Valuation
08:10AM  Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
Sep-06-16 03:55PM  With Solid Growth And Strong Pipeline, Argus Is Positive On Celgene's Long-Term Prospects
Sep-05-16 07:18PM  Next Up for Celgene's Crohn's Pill: A Snapshot Inside Patients' Colons (Updated)
Sep-02-16 01:03PM  Time to look at biotechs?
Sep-01-16 12:00PM  For Biotech ETFs, Its All About U.S. Presidential Politics
11:10AM  [$$] Novartis Carts Itself Off at Barrons.com
Aug-31-16 02:10PM  Celgene To Surge By Double-Digits After Big Tumble, Vetr Crowd Says
01:43PM  Celgene's Deep Pullback Reaches Key Support
01:32PM  Novartis Disbands Cell Therapy Unit; What's Ahead For Kite, Juno? at Barrons.com
10:24AM  Biotech: In Unfamiliar Territory? at Barrons.com
10:05AM  United Therapeutics Makes Novel Technologies a Priority
08:23AM  Celgene Corp. breached its 50 day moving average in a Bearish Manner : CELG-US : August 31, 2016
07:34AM  These 3 Billionaires Dumped Johnson & Johnson Stock. Should You? at Motley Fool
Aug-29-16 07:30AM  Celgene Corporation to Webcast at Upcoming Investor Conferences and R&D Deep Dive in September Business Wire
Aug-27-16 09:05AM  3 Great Stocks for Your 401(k) at Motley Fool
Aug-26-16 11:06AM  What Do Analysts Think about BioMarins Return Potential?
08:55AM  Franklin fund manager loads up on banks as profits rise at MarketWatch
Aug-25-16 09:38AM  Biotech Stocks: Oops, She Did It Again at Barrons.com
09:04AM  Will Teva Pharmaceutical Strengthen Specialty Pipeline in 3Q16?
08:40AM  Short Sellers Increase Bets in Major Biotechs at 24/7 Wall St.
Aug-24-16 03:41PM  Dear Pfizer, Stop Overpaying for Acquisitions! at Motley Fool
11:04AM  Imbruvica Continues to Report Better-than-Expected Sales in 2016
Aug-23-16 05:41PM  Mylan price hike happy?
02:04PM  What Are Analysts Recommendations for AbbVie in 2016?
12:09AM  [$$] Pfizers Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal
Aug-22-16 02:05PM  Medivation Scores Premium in Sale to Pfizer
01:18PM  Stocks Fluctuate as Wall Street Is Cautious Ahead of Yellen Speech
01:11PM  Here's Why a Gilead Stock Split Is Unlikely at Motley Fool
12:22PM  [$$] Pfizer's Medivation Deal Latest in Long Line of Similar Acquisitions at The Wall Street Journal
11:57AM  Biotech stocks rally as investors bet on the next big tie-up at CNBC
11:13AM  ETFs with exposure to Celgene Corp. : August 22, 2016
10:39AM  Understanding Medivations Premium Valuation
10:06AM  Pfizer buys Medivation $14 billion cash
05:00AM  From Nightmare Drug to Celgene Blockbuster, Thalidomide Is Back at Bloomberg
Aug-21-16 04:43PM  3 Top Stocks You Can Buy on Sale at Motley Fool
11:41AM  3 Reasons Medivation Is the Juiciest Target in Biotech at Motley Fool
Aug-19-16 12:39PM  Biotech Stocks: Trouble Ahead, Trouble Behind? at Barrons.com
09:04AM  CELG Expects This Investigational Drug to Be a Key Growth Driver
Aug-18-16 02:08PM  Gilead May Be Better Off Splitting Itself in Two, Analysts Say
12:50PM  How Much Medivation Can Really Fetch in a Buyout at 24/7 Wall St.
11:04AM  Despite Competitive Pressures, CELG Leads in Hematologic Oncology
09:04AM  Ozanimod May Prove to Be a Strong Growth Driver for Celgene
Aug-17-16 11:04AM  CELGs Otezla Continues Dominating US Inflammation and Immunology
09:04AM  Celgene Continues to Develop Its Hematologic Oncology Pipeline
Celgene Corporation discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases worldwide. It markets REVLIMID, an oral immunomodulatory drug for multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; ABRAXANE, a solvent-free chemotherapy product to treat breast, non-small cell lung, pancreatic, and gastric cancers; POMALYST/IMNOVID to treat multiple myeloma; and OTEZLA, a small-molecule inhibitor of phosphodiesterase 4 for psoriatic arthritis, psoriasis, ankylosing spondylitis, Behcet's disease, atopic dermatitis, and ulcerative colitis. The company's products also include VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); THALOMID for the patients with multiple myeloma and erythema nodosum leprosum; ISTODAX to treat cutaneous and peripheral T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN products. Its clinical stage products include OTEZLA for the treatment of various immune-inflammatory diseases; sotatercept for the treatment of renal anemia, beta-thalassemia and MDS; luspatercept for beta-thalassemia and MDS; CC-486 to treat MDS, AML, and solid tumors; CC-122 and CC-220 to treat hematological and solid tumor cancers, and inflammation and immunology diseases; PDA-002 for the treat diabetic foot ulcers and peripheral neuropathy; and PNK-007 for hematological malignancies treatment. The company has collaborative agreements with Novartis Pharma AG; Acceleron Pharma; Agios Pharmaceuticals, Inc.; Epizyme Inc.; Sutro Biopharma, Inc.; bluebird bio, Inc.; FORMA Therapeutics Holdings, LLC; Acetylon Pharmaceuticals, Inc.; OncoMed Pharmaceuticals, Inc.; NantBioScience, Inc.; AstraZeneca PLC; Lycera Corp.; Juno Therapeutics, Inc.; TriNetX, Inc.; Triphase Accelerator Corporation; and Nurix, Inc. The company was founded in 1980 and is headquartered in Summit, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BARKER RICHARD WDirectorSep 23Option Exercise36.9220,000738,40031,332Sep 26 04:08 PM
MARIO ERNESTDirectorSep 23Sale109.4215,0001,641,30090,058Sep 26 04:08 PM
BARKER RICHARD WDirectorSep 23Sale110.8220,0002,216,40011,332Sep 26 04:08 PM
KAPLAN GILLADirectorSep 19Option Exercise29.267,500219,45079,642Sep 20 04:42 PM
KAPLAN GILLADirectorSep 15Sale106.449,7101,033,53272,142Sep 16 04:15 PM
LOUGHLIN JAMES JDirectorAug 23Option Exercise26.3627,500724,85050,419Aug 24 04:28 PM
LOUGHLIN JAMES JDirectorAug 23Sale114.1027,5003,137,75022,919Aug 24 04:28 PM
CASEY MICHAEL DDirectorAug 22Sale114.0143,1344,917,70785,485Aug 23 04:29 PM
HUGIN ROBERT Jsee remarksJul 28Sale110.00100,00011,000,0001,022,201Aug 01 05:04 PM
MARIO ERNESTDirectorJul 01Option Exercise0.007330105,058Jul 05 04:32 PM
LOUGHLIN JAMES JDirectorJul 01Option Exercise0.00733022,919Jul 05 04:30 PM
Friedman Michael ADirectorJul 01Option Exercise0.0073300Jul 05 04:27 PM
KAPLAN GILLADirectorJul 01Option Exercise0.00733081,852Jul 05 04:28 PM
COX CARRIE SMITHDirectorJul 01Option Exercise0.00733023,146Jul 05 04:27 PM
BARKER RICHARD WDirectorJul 01Option Exercise0.00733011,551Jul 05 04:25 PM
CASEY MICHAEL DDirectorJul 01Option Exercise0.0073300Jul 05 04:26 PM
HUGIN ROBERT Jsee remarksJun 20Sale100.1675,0007,512,0001,122,201Jun 22 04:42 PM
KAPLAN GILLADirectorJun 17Option Exercise0.00333081,119Jun 17 04:18 PM
Friedman Michael ADirectorJun 17Option Exercise0.0033300Jun 17 04:14 PM
CASEY MICHAEL DDirectorJun 17Option Exercise0.0033300Jun 17 04:13 PM
COX CARRIE SMITHDirectorJun 16Option Exercise0.006,200022,413Jun 17 04:14 PM
MARIO ERNESTDirectorJun 16Option Exercise0.002,0550113,892Jun 16 06:57 PM
KAPLAN GILLADirectorJun 15Option Exercise0.006,200080,786Jun 17 04:18 PM
LOUGHLIN JAMES JDirectorJun 12Option Exercise0.002,068021,853Jun 13 05:10 PM
MARIO ERNESTDirectorJun 12Option Exercise0.002,0680103,992Jun 13 05:10 PM
KAPLAN GILLADirectorJun 12Option Exercise0.002,068074,586Jun 13 05:09 PM
BARKER RICHARD WDirectorJun 12Option Exercise0.002,068011,439Jun 13 05:08 PM
CASEY MICHAEL DDirectorJun 12Option Exercise0.002,06800Jun 13 05:08 PM
Friedman Michael ADirectorJun 12Option Exercise0.002,06800Jun 13 05:09 PM
Alles Mark JSee RemarksApr 29Option Exercise0.0011,0000164,636May 03 04:30 PM
HUGIN ROBERT Jsee remarksApr 29Option Exercise0.0060,00001,228,311May 03 04:19 PM
Smith Scott AndrewSee RemarksApr 29Option Exercise0.0010,000036,656May 03 09:28 PM
MARIO ERNESTDirectorApr 26Option Exercise31.805,000158,975101,924Apr 28 04:09 PM
KAPLAN GILLADirectorApr 04Sale101.8415,9671,626,07972,518Apr 05 04:15 PM
BONNEY MICHAEL WDirectorMar 03Buy103.012,000206,0282,000Mar 04 04:33 PM
LOUGHLIN JAMES JDirectorFeb 22Sale104.122,100218,65219,785Feb 24 04:56 PM
MARIO ERNESTDirectorFeb 01Option Exercise29.0018,600539,400101,049Feb 02 04:50 PM
Alles Mark JSee RemarksJan 29Option Exercise27.5121,938603,586139,685Feb 02 04:46 PM
HUGIN ROBERT Jsee remarksJan 15Option Exercise26.4522,680599,8411,168,311Jan 20 09:24 AM
CASEY MICHAEL DDirectorDec 23Sale122.1120,0002,442,200125,485Dec 28 04:03 PM
KAPLAN GILLADirectorDec 21Option Exercise16.2114,464234,461102,949Dec 22 04:12 PM
CASEY MICHAEL DDirectorDec 21Option Exercise110.8460,0006,650,400145,485Dec 22 04:11 PM
KAPLAN GILLADirectorDec 21Sale110.6214,4641,600,00888,485Dec 22 04:12 PM
Smith Scott AndrewSee RemarksDec 17Option Exercise0.005,000029,248Dec 18 04:22 PM
KARSEN PERRY Asee remarksDec 17Option Exercise0.007,500070,320Dec 18 04:21 PM
FOUSE JACQUALYN Asee remarksDec 17Option Exercise0.007,500061,611Dec 18 04:20 PM
Alles Mark JSee RemarksDec 17Option Exercise0.0011,6700123,117Dec 18 04:19 PM
Smith Scott AndrewSee RemarksDec 03Option Exercise0.0010,000029,433Dec 07 04:16 PM
CVS CVS Health Corporation daily Stock Chart
CVS [NYSE]
CVS Health Corporation
IndexS&P 500 P/E20.70 EPS (ttm)4.35 Insider Own0.20% Shs Outstand1.07B Perf Week0.84%
Market Cap95.87B Forward P/E13.68 EPS next Y6.58 Insider Trans-3.63% Shs Float1.06B Perf Month-4.12%
Income4.80B PEG1.42 EPS next Q1.57 Inst Own83.70% Short Float1.24% Perf Quarter-3.14%
Sales166.73B P/S0.58 EPS this Y16.80% Inst Trans-2.41% Short Ratio2.73 Perf Half Y-11.50%
Book/sh32.49 P/B2.77 EPS next Y12.20% ROA5.20% Target Price111.07 Perf Year-7.31%
Cash/sh1.13 P/C79.43 EPS next 5Y14.58% ROE13.20% 52W Range85.77 - 106.20 Perf YTD-6.83%
Dividend1.70 P/FCF18.52 EPS past 5Y13.30% ROI9.40% 52W High-15.33% Beta0.82
Dividend %1.89% Quick Ratio0.60 Sales past 5Y9.90% Gross Margin16.60% 52W Low4.84% ATR1.23
Employees155000 Current Ratio1.10 Sales Q/Q17.60% Oper. Margin5.40% RSI (14)37.95 Volatility0.97% 1.26%
OptionableYes Debt/Eq0.82 EPS Q/Q-23.50% Profit Margin2.90% Rel Volume0.97 Prev Close90.60
ShortableYes LT Debt/Eq0.74 EarningsAug 02 BMO Payout35.40% Avg Volume4.86M Price89.92
Recom1.80 SMA20-1.97% SMA50-4.84% SMA200-6.97% Volume4,707,274 Change-0.75%
Aug-04-16Reiterated Mizuho Buy $108 → $111
Aug-03-16Reiterated Deutsche Bank Hold $99 → $108
Jun-23-16Reiterated Mizuho Buy $117 → $108
Jun-22-16Reiterated Deutsche Bank Hold $105 → $99
Jun-20-16Downgrade Morgan Stanley Overweight → Equal-Weight
May-04-16Reiterated RBC Capital Mkts Outperform $110 → $115
May-04-16Reiterated Mizuho Buy $104 → $117
Mar-10-16Reiterated Barclays Overweight $110 → $115
Feb-10-16Reiterated Mizuho Buy $113 → $104
Feb-03-16Initiated Atlantic Equities Overweight
Jan-22-16Initiated Robert W. Baird Outperform $108
Dec-18-15Resumed Barclays Overweight $110
Dec-17-15Reiterated Oppenheimer Outperform $115 → $117
Dec-17-15Downgrade Goldman Buy → Neutral
Aug-28-15Reiterated Oppenheimer Outperform $122 → $119
Aug-10-15Reiterated Argus Buy $114 → $118
Aug-05-15Reiterated RBC Capital Mkts Outperform $117 → $132
Jul-22-15Reiterated Deutsche Bank Hold $108 → $117
Jun-18-15Initiated Oppenheimer Outperform $119
Jun-09-15Initiated Macquarie Outperform $115
Sep-23-16 12:00PM  Here's How to Find the Best Dividend Stocks at Motley Fool
11:00AM  Will e.l.f. Beauty Be a Thing of Beauty Post-IPO?
09:37AM  [$$] US politicians lament inaction over price-gouging drug companies at Financial Times
08:30AM  Rite Aid's (RAD) Q2 Earnings in Line, Sales Miss Estimates
Sep-22-16 03:08PM  Goldman: Stocks to Buy, Whoever Wins the Election (CVS, NOC) at Investopedia
02:42PM  [$$] Discount Cosmetics Firm E.l.f. Soars in Stock Market Debut at The Wall Street Journal
02:15PM  Will CVS Health (CVS) Stock Be Hurt by Delayed Curbside Service?
12:13PM  CVS Health Corporation Announces Quarterly Dividend PR Newswire
09:56AM  New Setback for Sanofi's Lantus Increases Need for M&A
09:31AM  Does IRS Exelon Win Threaten Triple Net 1031 Deals? at Forbes
Sep-21-16 01:43PM  One trader tries for a 575% profit in a months time at CNBC
06:22AM  [$$] CVS Catalysts Will Revive Stock at Barrons.com
Sep-19-16 08:30AM  CVS Health Expands Youth Drug Abuse Prevention Efforts for the 2016-2017 School Year PR Newswire
Sep-16-16 12:00PM  CVS Pharmacy Is Nearing Its 1-Year Low
11:45AM  3 Best Defensive Stocks to Buy in 2016 at Motley Fool
Sep-15-16 10:25AM  Bernstein Explains Amazon's 'Prime Now' Service
08:30AM  CVS Health's ScriptSync® Service Marks One Year Anniversary PR Newswire
Sep-14-16 03:05PM  Wal-Marts market share gain in grocery is Targets loss, analysts say at MarketWatch
11:00AM  CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Washington PR Newswire
Sep-13-16 08:24AM  3 Things You Should Know About the Healthcare Sector at Motley Fool
Sep-12-16 04:46PM  4 Cheap Pharma Stocks to Buy No Matter Who Is Elected
08:00AM  CVS Health Announces National Support of YMCA of the USA Diabetes Prevention Program and LIVESTRONG Foundation Initiatives PR Newswire
Sep-11-16 07:39AM  3 Great Dividend Stocks in the Bargain Bin for Retirees at Motley Fool
Sep-09-16 02:02PM  Why Walgreens Is a Long-Term Buy Now
12:20PM  New Update Spurs Renewed Hope On Rite Aid-Walgreens Deal
09:04AM  3 Reasons CVS Health Corporation Stock Could Rise at Motley Fool
Sep-08-16 04:46PM  Walgreens Signals FTC OK For Rite Aid Deal Near; Stock Breaks Out
10:38AM  Walgreens Will Divest Up To 1,000 Stores To Win Rite Aid Deal at Forbes
08:23AM  2 Stocks With Better Dividends Than CVS Health Corporation at Motley Fool
07:07AM  These 5 Blue Chips Are Breaking Out
Sep-07-16 08:00AM  CVS Health Increasing Access to Health Care with Annual Project Health Campaign PR Newswire
Sep-06-16 03:26PM  CVS must face revived lawsuit in U.S. over vitamin E label
12:18PM  Here's Why Walgreens' Growth Prospects Are Better Than Many Think
09:21AM  Forget CVS Health Corporation: Here Are 3 Better Dividend Stocks at Motley Fool
08:00AM  CVS Health to Host Third Annual In-Store Campaign to Support Innovative Cancer Research PR Newswire
Sep-03-16 12:26PM  Jim Simons Ups Stake in CVS Health
Sep-01-16 08:05AM  3 Stocks That Could Make You Rich at Motley Fool
Aug-31-16 12:00PM  CVS Health To Present At The Morgan Stanley Global Healthcare Conference PR Newswire
08:50AM  7 Healthy Dividend Stocks for Quality and Security at Kiplinger
Aug-30-16 02:26PM  Target's chief marketing officer to leave, join Uber
11:08AM  3 Bargain Stocks With Great Upside Potential at Forbes
08:43AM  The Consumer Rip-Off At The Heart Of The EpiPen Scandal at Forbes
12:06AM  [$$] Walgreens Forms Alliance With Prime Therapeutics at The Wall Street Journal
Aug-29-16 07:00PM  Cramer Remix: A stock up 27% this year, with more room to...
05:30PM  [$$] Walgreens Forms Alliance With Prime Therapeutics at The Wall Street Journal
02:23PM  Shareholders Push Walgreens to Drop Cigarettes at Investopedia
11:17AM  ETFs with exposure to CVS Health Corp. : August 29, 2016
Aug-28-16 11:51AM  3 Reasons CVS Health Corporation Stock Could Fall at Motley Fool
08:50AM  Mylan's EpiPen Price 'Cut' An Outdated Drug Industry PR Move at Forbes
Aug-26-16 02:21PM  What Tidings From the Tetons? Long-Awaited Yellen Speech Today
02:12PM  Pharmacy owner: There's a huge issue with PBMs
02:01PM  Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco
01:14PM  Express Scripts: Is EpiPen Reaction Overblown? at Barrons.com
11:14AM  EpiPen pricing under fire
08:15AM  CVS Health Corp. breached its 50 day moving average in a Bearish Manner : CVS-US : August 26, 2016
07:32AM  Here's How to Trade CVS After Its Breakdown
Aug-25-16 03:31PM  Follow the pharma money
02:52PM  PBM trade group: Blaming payers for price hikes is red he...
12:53PM  How Will Express Scripts (ESRX) Stock React to Mylan's EpiPen Controversy?
12:53PM  Here's Why CVS Health (CVS) Stock Is Slipping Today
12:37PM  CVS, Express Scripts shares feel Mylan's heat at MarketWatch
12:18PM  Why CVS, Express Scripts are Getting Crushed at Barrons.com
Aug-24-16 08:23PM  Why PharMerica Soared 13.4% Today at Motley Fool
Aug-23-16 12:59PM  Top trades for the 2nd half: CVS, SQ & more
09:04AM  Did Targets Fiscal 2Q16 Same-Store Sales Growth Meet Guidance?
Aug-22-16 08:30AM  CVS Health Research Institute Study Shows Value in Tailoring Medication Adherence Interventions to Specific Patient Populations PR Newswire
01:00AM  AAPL, CVS, URBN: Jim Cramer's Views
Aug-19-16 11:56AM  Moody's Upgrades One, Affirms One, and Downgrades One Class of FUNCM 1999-C2 at Moody's
Aug-18-16 04:27PM  RenTech Loaded Up On Mastercard, Nike, More in Q2 at Insider Monkey
12:41PM  CVS Health and the CVS Health Foundation Announce $100K Donation In Support of Louisiana Flood Relief Efforts PR Newswire
08:11AM  Why Selling Drugs Has Gotten Tougher for Target
Aug-17-16 07:01PM  Cramer: Target's Excuses Really Don't Cut It
04:34PM  Target Slashes Profit Guidance Amid Weak Apple Sales
02:14PM  Target cuts outlook as it sees fewer customers in stores
01:25PM  Target: PrudentBut Painful at Barrons.com
10:00AM  Target Blames Apple, Two Other Things for Weak Sales
09:30AM  CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations in Colorado PR Newswire
Aug-16-16 04:30PM  Can Target Withstand Amazons Wrath?
04:00PM  5 Stocks to Watch Before the Market Opens Tomorrow
12:26PM  CVS Health Corporation in 5 Charts at Motley Fool
08:30AM  CVS Health Survey Reveals Two in Five Americans Make Multiple Trips to get Entire Household Vaccinated against the Flu PR Newswire
Aug-15-16 12:58PM  What CVS and Express Scripts' Drug Exclusion Lists Means for Your Portfolio
10:19AM  ETFs with exposure to CVS Health Corp. : August 15, 2016
Aug-14-16 08:03AM  70 or Older? 3 Stocks You Should Consider Buying at Motley Fool
Aug-12-16 03:39PM  Will Rising Web Sales Help Targets 2Q17 Revenue Growth?
03:39PM  What Investors Expect from Targets Fiscal 2Q17 Earnings
12:10PM  Friday links: unsolvable puzzles
09:30AM  CVS Health Makes Overdose-Reversal Drug Naloxone Available Without A Prescription in Idaho PR Newswire
Aug-11-16 06:03PM  Ray Dalio's 5 Biggest 2nd-Quarter New Stock Buys
10:30AM  Moody's Upgrades Two and Affirms Three Classes of CSFB 1998-C2 at Moody's
08:49AM  CVS Health introduces CVS Pay at MarketWatch
08:30AM  CVS Pharmacy Launches Breakthrough, End-to-End Mobile Payment Experience PR Newswire
Aug-10-16 04:24PM  Is The Retail Sector Signaling Recession?
Aug-09-16 02:00PM  CVS Health (CVS) Stock Higher, Earnings Estimates Raised at Leerink
Aug-06-16 01:04PM  CVS HEALTH CORP Financials
Aug-05-16 07:30PM  Week in Review: S&P 500 Ends First Week of August Positive After Robust Jobs Report
04:51PM  Novo Nordisk Plunges On Guidance Cut As Diabetes Sales Struggle
10:15AM  Post Earnings Coverage as CVS Tops Earning Estimates
10:15AM  Post Earnings Coverage as CVS Tops Earning Estimates Accesswire
Aug-04-16 02:49PM  ETFs with exposure to CVS Health Corp. : August 4, 2016
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MERLO LARRY JPresident and CEOMay 05Option Exercise36.2338,2471,385,689280,381May 06 04:26 PM
GOLD STEPHEN JEVP & CIOMay 05Option Exercise47.299,798463,34731,358May 06 04:29 PM
GOLD STEPHEN JEVP & CIOMay 05Sale105.009,7981,028,79021,560May 06 04:29 PM
Brennan Troyen AEVP and Chief Medical OfficerMay 05Sale105.007,517789,28569,601May 06 04:28 PM
MERLO LARRY JPresident and CEOMay 05Sale105.0038,2474,015,935242,134May 06 04:26 PM
GOLD STEPHEN JEVP & CIOApr 01Option Exercise47.2921,9221,036,69142,048Apr 05 06:39 PM
Sussman AndrewEVP & Pres, CVS MinuteClinicApr 01Sale105.002,844298,62011,041Apr 05 07:21 PM
GOLD STEPHEN JEVP & CIOApr 01Sale105.0021,9222,301,81020,126Apr 05 06:39 PM
Brennan Troyen AEVP, Chief Medical OfficerMar 09Sale100.006,755675,50069,601Mar 11 04:08 PM
Roberts Jonathan CEVP & President, CVS/caremarkFeb 11Sale92.8623,3552,168,74528,644Feb 11 05:17 PM
MERLO LARRY JPresident and CEOFeb 01Option Exercise28.1046,3931,303,643208,021Feb 02 04:17 PM
MERLO LARRY JPresident and CEOFeb 01Sale96.1446,3934,460,010161,628Feb 02 04:17 PM
MERLO LARRY JPresident and CEOJan 11Option Exercise28.1046,3931,303,643208,006Jan 13 04:16 PM
MERLO LARRY JPresident and CEOJan 11Sale95.0046,3934,407,335161,613Jan 13 04:16 PM
Finucane Anne A.DirectorJan 04Sale95.872,000191,74914,719Jan 05 05:10 PM
Brennan Troyen AEVP, Chief Medical OfficerOct 27Option Exercise54.5323,6031,287,07285,444Oct 28 04:50 PM
Brennan Troyen AEVP, Chief Medical OfficerOct 27Sale105.0023,6032,478,31561,841Oct 28 04:50 PM
XLV Health Care Select Sector SPDR ETF daily Stock Chart
XLV [NYSE]
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.57%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.34%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter6.08%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.12 Perf Half Y7.14%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year9.75%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range61.97 - 75.71 Perf YTD1.48%
Dividend1.09 P/FCF- EPS past 5Y- ROI- 52W High-4.55% Beta-
Dividend %1.51% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low16.61% ATR0.75
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)45.38 Volatility0.80% 0.94%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.66 Prev Close73.11
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume8.43M Price72.26
Recom- SMA20-0.13% SMA50-1.76% SMA2003.34% Volume5,529,538 Change-1.16%
Sep-26-16 02:02PM  Increased Government Spending Can Have a Domino Effect
11:05AM  A Look at Johnson & Johnsons Recent Stock Performance
10:05AM  Inside Johnson & Johnsons Latest US Medical Device Launch
08:06AM  Johnson & Johnson Gets FDA Approval for Type 2 Diabetes Drug
07:23AM  Theres big volatility ahead for this sector: Goldman Sachs at CNBC
06:59AM  Pfizer decides against splitting into two companies at MarketWatch
Sep-22-16 11:04AM  Hows Gilead Sciences Expected to Perform in 2016?
Sep-19-16 05:04PM  Rise in Consumer Price Index Likely to Push Fed Rate Hike
03:00PM  August Jobs Report: Labor Markets Rapidly Changing Composition
11:04AM  St. Jude Medicals Stock Prices Are on a Declining Trend
08:05AM  What Analysts Think about Bristol-Myers Squibb
Sep-16-16 01:30PM  This Advisory Firms Name Held True to Form for St. Jude Medical
Sep-15-16 02:41PM  Stop Wasting Energy On The VIX
12:46PM  Stryker Acquires Ivy Sports Medicine to Strengthen Its Business
11:38AM  The Case for Health Care Stocks (Especially Biotech) at Barrons.com
08:43AM  Price of pharma innovation: Pro
08:41AM  Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial at MarketWatch
06:33AM  Executive Edge: Improving health care
Sep-12-16 02:15PM  Why Is The Fed So Hesitant To Raise Interest Rates?
05:51AM  Where to create alpha amid rising rates: Pro
Sep-09-16 04:28PM  FDA Approves Medtronics Enlite Sensor for iPro2 CGM System
04:19PM  Pfizers Essential Health Business: What You Need to Know
03:04PM  Market Watches to See if Biogen Will Meet Its Raised Guidance
12:37PM  What Are Analysts Recommendations for Perrigo in 2016?
11:04AM  Analysts Look for Celgene to Offer Striking Returns in 2016
08:06AM  Rubenstein Thinks That Healthcare Spending Will Increase in the US
07:34AM  Politic-proofing your portfolio: Pro
Sep-08-16 09:59AM  Why Leon Cooperman Thinks Interest Rate Normalization Is Required
08:04AM  How Can Revlimid Eventually Lead the Lymphoma Space?
Sep-07-16 06:04PM  How Cepheid Fits Strategically into DHRs Portfolio
04:04PM  DHR to Reap $200 Million in Cost Synergies, Revenue through Buy
02:23PM  What Made Cepheid Attractive to Danaher?
08:05AM  Will the August Jobs Report Soften the Feds Rate Hike Urgency?
Sep-02-16 12:30PM  Raymond James: Abbvie has value-enhancing catalysts
08:04AM  An Overview of Pfizers Oncology Business
Sep-01-16 10:04AM  Regenerons Growth Opportunities: Praluent, Sarilumab, and Dupilumab
08:04AM  A Look at Pfizers Innovative Health Business
Aug-31-16 01:22PM  Analysts Recommendations for Edwards Lifesciences in 2016
12:34PM  Analysts Recommendations for C.R. Bard in 2016
10:48AM  Healthcare ETFs Need Some Rest
08:05AM  Johnson & Johnsons Medical Devices Segment
Aug-30-16 06:04PM  How StrataGraft Could Benefit Mallinckrodts Hospital Portfolio
03:04PM  Competition in the Robotics Surgical Space Impacts Intuitive Surgical
02:13PM  America's opioid problem
01:35PM  Surgeon General on opioids, zika and drug costs
09:39AM  Biotech ETFs Back In The Spotlight
07:47AM  Big trader doubles down on health care
Aug-29-16 02:03PM  US health care system needs more transparency: Pro
01:09PM  EpiPen as metaphor for broken health care system: Brill
12:26PM  Healthcare's best bets following generic EpiPen
11:05AM  A Look at Allergans Growth Pharma Model
10:05AM  How Allergan Is Still Benefiting from Actavis Deal
08:05AM  What Investors Should Know about the Pfizer-Anacor Deal
Aug-26-16 08:05AM  Third Point Lowered Its Position in Dow Chemical
Aug-25-16 03:19PM  Janus Capital Increased Position in Microsoft in 2Q16
08:30AM  Mylan stock set to snap four-day losing streak at MarketWatch
Aug-23-16 04:02PM  Best ETFs: Sector Funds at Forbes
03:04PM  How AbbVie Expects Risankizumab to Be a Transformative Therapy
02:00PM  Return Analysis: Health Care Select Sector SPDR (XLV) at Investopedia
12:27PM  An Appealing, Cost-Efficient Healthcare ETF
08:16AM  It Could Be An Interesting Ride For Healthcare ETFs
Aug-22-16 12:01PM  ETFs in Focus on Pfizer's Medivation Acquisition
11:05AM  How Did Bristol-Myers Squibbs Virology Segment Perform?
Aug-18-16 11:04AM  Mylan Expects to Be a Dominant Player in the Respiratory Market
Aug-17-16 03:06PM  Troubled drug company Valeant handed second upgrade of the week at MarketWatch
12:02PM  Brean Downgrades The Healthcare Sector On Technical Indicators
09:04AM  How Did Mercks Animal Health Segment Perform?
08:58AM  Valeant's stock soars after Morgan Stanley analyst turns bullish at MarketWatch
06:46AM  Healthcare Investors May Be Pricing In A Clinton Victory
04:58AM  Will the Cyclical Sector Outperform the Defensive Sector?
Aug-16-16 12:29PM  According to Janus, These Sectors Are Immune to Rising Inflation
05:52AM  Market melt-up play: Health care
Aug-15-16 11:05AM  Revlimid Is Expected to Become a Major Lymphoma Drug by 2020
08:45AM  Trader buys time for rally in health care
Aug-11-16 12:28PM  Valeant sinks on criminal probe
07:32AM  Valeants volatile shares are spooky how about trying its bonds instead? at MarketWatch
Aug-10-16 09:04AM  Becton Dickinsons Updated Guidance for 2016
08:02AM  S&P 500 over & underweights
Aug-09-16 12:00PM  Buy Mylan, Ride the Momentum
10:26AM  Changes to Richard Bernstein Advisors US Equities in 2016
Aug-08-16 05:46PM  How Did Regeneron Perform in 2Q16?
10:45AM  Sector ETFs: Selling into Upside Breakouts?
10:00AM  Bristol-Myers' stock extends slide after downgrade, Merck upgraded at MarketWatch
09:55AM  Non-Farm Payroll Steadies after 2 Months of Data Abberation
07:54AM  Bob Doll's top sector plays
Aug-05-16 09:04AM  How Elanco, Eli Lillys Animal Health Segment, Performed in 2Q
Aug-03-16 09:55AM  Pfizer: Five Years is a Long Time to Wait for Nothing at Barrons.com
Aug-02-16 02:25PM  361 Capital Weekly Research Briefing: Time to Separate the Wheat from the Chaff...
12:26PM  Barron's #1 advisor on Fed's next move
12:18PM  Is an August correction coming?
11:28AM  Buy Pfizer's Stock for Healthy Long-Term Gains
Aug-01-16 01:45PM  Revenue recession could finally be over at MarketWatch
11:06AM  C.R. Bards New Treatments for Hernia Are Key Growth Drivers
11:04AM  Gilead Continued Share Buybacks, Dividend Payouts in 2Q16
09:18AM  GICS Sector ETFs: Why Were Seeing Brexit-Style Outflows
09:09AM  These Drugs Were Key Growth Drivers for Amgens Revenue in 2Q16
Jul-29-16 11:36AM  Buy Merck on Near-Term Weakness
07:40AM  Why some see unloved health-care stocks as a screaming buy at MarketWatch
07:15AM  Beyond Merck's yield is value: Pro
Jul-28-16 09:07AM  What Drove Edwards Lifesciences THVT Revenues in 2Q16?
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
CAG ConAgra Foods, Inc. daily Stock Chart
CAG [NYSE]
ConAgra Foods, Inc.
IndexS&P 500 P/E39.13 EPS (ttm)1.10 Insider Own0.20% Shs Outstand439.35M Perf Week-0.37%
Market Cap18.91B Forward P/E16.43 EPS next Y2.62 Insider Trans-30.04% Shs Float438.41M Perf Month-6.58%
Income479.60M PEG5.34 EPS next Q0.48 Inst Own78.50% Short Float0.84% Perf Quarter-7.85%
Sales11.64B P/S1.62 EPS this Y-36.90% Inst Trans1.34% Short Ratio1.25 Perf Half Y-2.08%
Book/sh8.48 P/B5.08 EPS next Y9.12% ROA-4.70% Target Price50.70 Perf Year6.10%
Cash/sh1.90 P/C22.66 EPS next 5Y7.33% ROE-19.30% 52W Range37.32 - 48.55 Perf YTD3.87%
Dividend1.00 P/FCF56.50 EPS past 5Y-10.30% ROI7.30% 52W High-11.35% Beta0.34
Dividend %2.32% Quick Ratio0.80 Sales past 5Y-1.20% Gross Margin27.10% 52W Low15.34% ATR0.64
Employees20900 Current Ratio1.40 Sales Q/Q-9.50% Oper. Margin7.70% RSI (14)35.59 Volatility1.37% 1.42%
OptionableYes Debt/Eq1.49 EPS Q/Q-112.10% Profit Margin-5.90% Rel Volume1.14 Prev Close43.55
ShortableYes LT Debt/Eq1.32 EarningsSep 29 BMO Payout- Avg Volume2.92M Price43.04
Recom2.40 SMA20-3.73% SMA50-6.22% SMA200-2.12% Volume3,320,940 Change-1.17%
Jul-01-16Reiterated RBC Capital Mkts Sector Perform $48 → $50
Apr-08-16Reiterated Jefferies Buy $50 → $52
Apr-04-16Reiterated RBC Capital Mkts Sector Perform $46 → $48
Feb-25-16Resumed Goldman Neutral $48
Feb-12-16Upgrade BofA/Merrill Neutral → Buy
Dec-16-15Initiated Jefferies Buy
Sep-25-15Reiterated Deutsche Bank Hold $38 → $43
Jul-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $37 → $50
Jul-01-15Upgrade BofA/Merrill Underperform → Neutral
Jun-22-15Upgrade JP Morgan Neutral → Overweight
Jun-19-15Reiterated Deutsche Bank Hold $36 → $38
Jun-19-15Reiterated Bernstein Mkt Perform $37 → $44
Sep-19-14Reiterated RBC Capital Mkts Sector Perform $31 → $35
Feb-12-14Reiterated Deutsche Bank Hold $35 → $31
Nov-26-13Initiated RBC Capital Mkts Sector Perform $33
Sep-11-13Reiterated Barclays Overweight $40 → $38
Apr-03-13Reiterated Deutsche Bank Hold $35 → $40
Feb-20-13Reiterated Deutsche Bank Hold $31 → $32
Jan-24-13Reiterated UBS Buy $38 → $36
Nov-28-12Reiterated Deutsche Bank Hold $29 → $31
Sep-26-16 02:00PM  ConAgra Foods Acquires Frontera, Red Fork and Salpica Brands Business Wire
Sep-25-16 09:45AM  Week Ahead: A Quieter Week but With the Fed Still on Watch
Sep-23-16 03:44PM  ConAgra Foods (CAG) Stock Price Target Reduced at Deutsche Bank
08:00AM  ConAgra Foods Announces Dividend Payment Business Wire
Sep-22-16 07:30AM  ConAgra Foods Announces Details of Fiscal 2017 First Quarter Earnings Release and Conference Call Business Wire
Sep-20-16 04:17PM  Wilson joins roster of companies seeking home-field advantage in downtown Chicago at MarketWatch
Sep-19-16 05:15PM  [$$] Food Stocks Look Spoiled at Barrons.com
01:15PM  Oppenheimer Has Rated Hormel Foods Perform
Sep-12-16 08:00AM  3 Healthy Swaps to Spice up your Busy, Back-to-School Routine from Healthy Choice® PR Newswire
06:22AM  Five Packaged Foods Stocks to Buy Now at Insider Monkey
Sep-09-16 01:40PM  Slumping U.S. meat prices help feed appetite for jerky
11:04AM  Hormel Foods Reported Mixed Price Movement on September 7
Sep-08-16 05:39PM  ConAgra Foods Named to Dow Jones Sustainability North America Index for Sixth Consecutive Year Business Wire
Sep-06-16 09:37AM  ConAgra (CAG) Poised to Grow Despite Macroeconomic Woes
Sep-02-16 05:02PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibi
08:14AM  Treehouse Foods (THS) Appears Attractive: Time to Buy?
Aug-25-16 02:04PM  Why Edward Jones Upgraded Hormel Foods to a Buy
Aug-24-16 01:07PM  How Did J.M. Smucker Perform in 1Q17?
Aug-23-16 04:22PM  J.M. Smucker Cuts Sales View, As Pet Food Weakness To Last
03:04PM  Credit Suisse Upgraded Hormel Foods to Outperform
12:04PM  Wall Street Analysts Recommendations for Hormel after 3Q16
09:04AM  What Are Analysts Expectations for J.M. Smucker ahead of 1Q17?
Aug-19-16 01:12PM  How Did Hormel Foods Perform in 3Q16?
Aug-18-16 01:53PM  Rough Patch Continues for Barry Rosensteins JANA Partners at Insider Monkey
01:25PM  Joel Greenblatt Buys Fox, ConAgra and Intuit
09:05AM  Analyzing the Ratings and Recommendations for Hain Celestial
07:02AM  What Made J.M. Smuckers Stock Rally 15% since 4Q16 Results?
Aug-17-16 03:50PM  Pinnacle Foods Declares Dividend of $0.29 Per Share
11:04AM  What Do Wall Street Analysts Recommend for Hormel Foods?
Aug-16-16 11:04AM  Analysts Recommendations for HAIN before Fiscal 4Q16 Earnings
06:54AM  Whats Expected from Hormel Foods Fiscal 3Q16 Earnings?
Aug-15-16 01:22PM  Why is Time (TIME) Stock Popping Today?
11:41AM  Rosenstein's Jana Partners: Walgreens Stake Gets Slashed 60%; Trims ConAgra; Adds AutoNation at Barrons.com
11:04AM  Will Hain Celestials Revenue Beat Estimates in Fiscal 4Q16?
Aug-12-16 11:24AM  Judge pushes ConAgra salmonella hearing into fall
Aug-11-16 11:04AM  Why FMCs Health and Nutrition Segments Revenue Fell in 2Q16
09:05AM  Kraft Heinz: 71% of Analysts Recommend a Buy after Fiscal 2Q16
Aug-10-16 12:10AM  [$$] Packaged Foods New Selling Point: Fewer Ingredients at The Wall Street Journal
Aug-09-16 01:26PM  Packaged Foods New Selling Point: Fewer Ingredients
Aug-08-16 02:50PM  Huge private company names new CEO to take over from OP leader at bizjournals.com
Aug-07-16 10:00PM  Court to hold hearing over ConAgra's 2007 Georgia Salmonella outbreak at bizjournals.com
Aug-06-16 01:45PM  ConAgra salmonella case nearing end a decade after outbreak
Aug-05-16 03:24PM  Kraft Heinz: "They Must Be Doing Something Right" at Barrons.com
10:19AM  TreeHouse (THS) Posts in Line Q2 Earnings, Misses Sales
09:04AM  Analyst Recommendations for Hershey after Its 2Q16 Results
Aug-04-16 03:32PM  TreeHouse Foods: It's Never Good News When the CFO Leaves at Barrons.com
10:49AM  [$$] TreeHouse Foods Profit Halves; CFO to Retire at The Wall Street Journal
09:05AM  How Fresh Milk, Pure Sugar Cane May Boost Hersheys Revenue
Aug-03-16 11:06AM  Why Did Mead Johnson Nutritions Earnings Rise 16% in 2Q16?
09:20AM  Corporate Welfare In Wine-Soaked Modesto, California at Forbes
Aug-01-16 04:41PM  Kellogg Company Has Declared a Quarterly Dividend
11:09AM  How Has Pilgrims Pride Made Room for Strategic Investments?
11:05AM  71% of Analysts Recommend Buys on KHC before Its 2Q16 Results
09:06AM  Whats Kraft Heinzs Outlook for 2016?
Jul-29-16 07:06PM  [$$] Deal Close Announcements: July 25-29 at The Wall Street Journal
01:17PM  Jefferies Increases ConAgra Foods Price Target to $56 per Share
09:07AM  Whats Expected of Kraft Heinzs Revenue in 2Q16?
Jul-28-16 12:45PM  California's tomato business is just plain rotten and farmers are seeing red at CNBC
Jul-27-16 03:24PM  ConAgra Foods (CAG) Stock Price Target Raised at Jefferies
11:09AM  ConAgra Foods Completed the Sale of Its Two Businesses
08:23AM  ConAgra Foods, Inc. breached its 50 day moving average in a Bearish Manner : CAG-US : July 27, 2016
Jul-25-16 04:33PM  Platinum Equity Completes Acquisition of JM Swank Marketwired
04:27PM  ConAgra Foods Completes Sales of JM Swank and Spicetec Flavors & Seasonings Business Wire
12:52PM  ETFs with exposure to ConAgra Foods, Inc. : July 25, 2016
Jul-22-16 01:06PM  Key Moving Averages: Comparing Bunge and Its Peers
10:54AM  ConAgra Foods, Inc. :CAG-US: Earnings Analysis: Q4, 2016 By the Numbers : July 22, 2016
09:03AM  ConAgra Foods, Inc. :CAG-US: Earnings Analysis: 2016 By the Numbers : July 22, 2016
Jul-21-16 03:32PM  Why Kellogg Company Fell 5% on July 20
01:04PM  CONAGRA FOODS INC /DE/ Financials
12:55PM  ConAgra closing another St. Louis plant, laying off 69 at bizjournals.com
Jul-20-16 01:48PM  ConAgra Extends P.F. Chang's Home Menu Products' Recall On Possible Metal Fragments Presence
12:51PM  Roving candy, cookie towers: How supermarkets sway shoppers
Jul-19-16 05:16PM  CONAGRA FOODS INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Finan
12:07PM  Will Ingredion Continue Positive Earnings Growth in 2Q16?
Jul-18-16 01:06PM  ConAgra Foods Appoints David Marberger as CFO
10:09AM  P.F. Chang's Frozen Meals Recalled Over Metal Shards
08:30AM  This Company Could Be In The Economic Sweet Spot
Jul-16-16 03:08PM  ConAgra Foods Expands Recall of P.F. Changs Home Menu Brand Meals Due to Potential Presence of Foreign Material Business Wire
Jul-15-16 07:13PM  Wolverine World Wide Declared Dividend of $0.06 per Share
07:10PM  Who Were the Outliers in the Consumer Space on July 14?
02:14PM  CONAGRA FOODS INC /DE/ Files SEC form 10-K, Annual Report
07:47AM  CFO Moves: ConAgra, Prestige Brands, Brink's at The Wall Street Journal
Jul-14-16 06:00PM  [$$] ConAgra Foods Names Marberger as Next CFO at The Wall Street Journal
05:08PM  ConAgra hires CFO from Prestige Brands
04:30PM  ConAgra Foods Names David Marberger Chief Financial Officer Business Wire
03:35PM  ConAgra Moves Forward With Spinoff Plans at Investopedia
12:20AM  [$$] Business Briefs at The Wall Street Journal
Jul-13-16 07:57PM  [$$] Business Watch at The Wall Street Journal
05:05PM  ConAgra Foods Declares Dividend of $0.25 per Share
11:42AM  ConAgra Foods (CAG) Stock Up, Names CEO of Lamb Weston Spinoff
10:36AM  Why Traders Are Talking About Allergan, Teva, and 3 Other Stocks Today at Insider Monkey
08:25AM  ConAgra files to split into two companies at bizjournals.com
08:14AM  [$$] ConAgra Names CEO, Chairman of Potato Business Spinoff at The Wall Street Journal
07:47AM  ConAgra Foods Proceeds With Spinoff of Lamb Weston Division at Bloomberg
07:40AM  ConAgra Foods Files Form 10 For Planned Spinoff
06:57AM  ConAgra files for split into two companies, names executives of new Lamb Weston at MarketWatch
06:35AM  ConAgra Foods Files Form 10 Registration Statement for Planned Spin-off, Announces Key Lamb Weston Leadership Positions Business Wire
Jul-12-16 02:01PM  ConAgra Foods Dividend Offers 2.10% Yield
12:00PM  Weekly CFO Sells Highlights
09:58AM  ConAgra (CAG) Adds Organic Items to Healthy Choice Menu
ConAgra Foods, Inc., together with its subsidiaries, operates as a food company in North America. The company operates through two segments: Consumer Foods and Commercial Foods. The Consumer Foods segment principally sells branded food in various categories, including meals, entrees, condiments, pasta, sides, snacks, and desserts in various retail channels across frozen, refrigerated, and shelf-stable temperature. It offers its products under the ACT II, Banquet, Blue Bonnet, Chef Boyardee, DAVID, Egg Beaters, Healthy Choice, Hebrew National, Hunt's, Marie Callender's, Orville Redenbacher's, PAM, Peter Pan, Reddi-wip, Slim Jim, Snack Pack, Swiss Miss, Van Camp's, and Wesson brands. The Commercial Foods segment sells branded and private label food and ingredients, primarily to commercial, foodservice, restaurant, food manufacturing, and industrial customers. It provides food items, such as frozen potato and sweet potato items; and various vegetable, spice, and frozen bakery goods under the Lamb Weston and Spicetec Flavors & Seasonings brands. ConAgra Foods, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Serrao DarrenEVP, Chief Growth OfficerSep 01Option Exercise0.003,23503,235Sep 06 06:04 PM
Wise Robert GSVP, Corporate ControllerJul 15Option Exercise36.8915,708579,46834,326Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 15Sale47.9015,708752,36618,618Jul 19 09:35 PM
Wise Robert GSVP, Corporate ControllerJul 14Option Exercise30.8917,245532,69835,863Jul 18 04:21 PM
Wise Robert GSVP, Corporate ControllerJul 14Sale48.1917,245830,97418,618Jul 18 04:21 PM
JURGENSEN WILLIAM GDirectorJul 08Option Exercise24.549,000220,860119,356Jul 08 04:51 PM
JURGENSEN WILLIAM GDirectorJul 08Sale47.884,636221,972114,720Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Option Exercise24.549,000220,86089,850Jul 08 04:50 PM
GOLDSTONE STEVEN FDirectorJul 07Option Exercise24.5481,1681,991,863191,922Jul 08 04:51 PM
BUTLER STEPHEN GDirectorJul 07Sale48.104,607221,59785,243Jul 08 04:50 PM
GOLDSTONE STEVEN FDirectorJul 07Sale48.0441,4701,992,132150,452Jul 08 04:51 PM
Johri RajiveDirectorJul 06Option Exercise21.4715,000322,05051,259Jul 08 04:56 PM
Johri RajiveDirectorJul 06Sale47.5315,000712,87736,259Jul 08 04:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Option Exercise36.8936,6541,352,16655,272Jul 07 08:47 PM
Gehring JohnEVP and CFOJul 05Option Exercise34.58159,0575,499,729218,766Jul 07 08:56 PM
Gehring JohnEVP and CFOJul 05Sale48.14159,0577,657,06859,709Jul 07 08:56 PM
Wise Robert GSVP, Corporate ControllerJul 05Sale48.1636,6541,765,27118,618Jul 07 08:47 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Option Exercise30.8912,992401,323118,541Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 12Sale46.3512,992602,179105,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Option Exercise24.7410,000247,400115,549Apr 13 04:51 PM
MESSEL SCOTT ESVP, Treasurer&Asst. SecretaryApr 11Sale46.2510,000462,500105,549Apr 13 04:51 PM
McGough Thomas MPresident, Consumer FoodsApr 07Option Exercise26.1560,0001,569,000116,341Apr 11 04:50 PM
McGough Thomas MPresident, Consumer FoodsApr 07Sale46.0060,0002,760,00056,341Apr 11 04:50 PM
Gehring JohnEVP and CFOJan 06Option Exercise25.45320,0008,142,400379,709Jan 08 04:26 PM
Wise Robert GSVP, Corporate ControllerJan 06Option Exercise30.8922,992710,22341,610Jan 08 04:30 PM
Wise Robert GSVP, Corporate ControllerJan 06Sale41.9722,992965,00918,618Jan 08 04:30 PM
Gehring JohnEVP and CFOJan 06Sale41.67320,00013,335,32859,709Jan 08 04:26 PM
Johri RajiveDirectorDec 24Option Exercise16.806,750113,40038,319Dec 29 05:55 PM
Johri RajiveDirectorDec 24Sale42.216,750284,89731,918Dec 29 05:55 PM
GILD Gilead Sciences Inc. daily Stock Chart
GILD [NASD]
Gilead Sciences Inc.
IndexS&P 500 P/E7.10 EPS (ttm)11.35 Insider Own0.40% Shs Outstand1.32B Perf Week2.06%
Market Cap106.39B Forward P/E6.94 EPS next Y11.62 Insider Trans-19.87% Shs Float1.31B Perf Month1.28%
Income16.35B PEG- EPS next Q2.88 Inst Own80.50% Short Float1.23% Perf Quarter3.65%
Sales32.37B P/S3.29 EPS this Y62.00% Inst Trans-2.77% Short Ratio1.51 Perf Half Y-11.53%
Book/sh11.64 P/B6.93 EPS next Y-1.17% ROA32.70% Target Price104.50 Perf Year-17.80%
Cash/sh6.63 P/C12.16 EPS next 5Y-0.21% ROE100.80% 52W Range76.21 - 108.83 Perf YTD-19.01%
Dividend1.88 P/FCF7.32 EPS past 5Y48.30% ROI45.90% 52W High-25.92% Beta1.10
Dividend %2.33% Quick Ratio1.60 Sales past 5Y32.60% Gross Margin87.10% 52W Low5.79% ATR1.30
Employees8000 Current Ratio1.80 Sales Q/Q-5.70% Oper. Margin63.00% RSI (14)56.14 Volatility1.73% 1.56%
OptionableYes Debt/Eq1.42 EPS Q/Q-11.50% Profit Margin50.50% Rel Volume0.84 Prev Close81.37
ShortableYes LT Debt/Eq1.38 EarningsOct 25 AMC Payout15.20% Avg Volume10.68M Price80.62
Recom2.20 SMA202.47% SMA500.47% SMA200-7.45% Volume8,998,470 Change-0.92%
Sep-12-16Initiated Berenberg Buy $112
Sep-06-16Upgrade Jefferies Hold → Buy
Jul-29-16Downgrade Argus Buy → Hold
Jul-26-16Reiterated RBC Capital Mkts Outperform $120 → $105
Jul-26-16Downgrade Needham Buy → Hold
Jun-01-16Initiated Gabelli & Co Buy $109
Apr-29-16Reiterated UBS Buy $130 → $118
Apr-29-16Downgrade Maxim Group Buy → Hold
Mar-16-16Reiterated Leerink Partners Outperform $130 → $127
Feb-25-16Initiated Citigroup Buy $110
Feb-12-16Reiterated Maxim Group Buy $137 → $115
Feb-03-16Reiterated RBC Capital Mkts Outperform $130 → $120
Feb-03-16Reiterated Piper Jaffray Overweight $134 → $114
Feb-03-16Reiterated Oppenheimer Outperform $124 → $120
Feb-03-16Reiterated Barclays Overweight $130 → $115
Feb-03-16Initiated Standpoint Research Buy $110
Jan-20-16Initiated Credit Suisse Outperform $125
Jan-15-16Upgrade BofA/Merrill Underperform → Neutral $107
Oct-28-15Reiterated Maxim Group Buy $129 → $137
Oct-20-15Reiterated Oppenheimer Outperform $120 → $124
Sep-26-16 04:03PM  Wall Street Sells Off on Worries Over Clinton-Trump Showdown
02:46PM  Who's Doing What To Whom In The Back Seat Of The Car? at Forbes
02:38PM  Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies
02:29PM  Will Gilead (GILD) Stock Be Helped by Positive Crohn's Drug Results?
11:04AM  Whats the Upside Potential for Gilead?
10:46AM  Gilead Sciences: A 'Slight Uplift' for R&D Strategy? at Barrons.com
10:05AM  Gileads TAF-Based Regimen Should Drive HIV Franchise Revenue
08:06AM  How Gilead Dominates the HCV Space
Sep-24-16 09:24AM  7 Best Roth IRA Stocks for 2017 at Motley Fool
Sep-23-16 07:01PM  Cramer: Here Are the Reasons the Market Is Hated
03:04PM  Population Dynamics for Gileads HCV Products
01:04PM  Why Analysts Expect Gileads Revenue to Fall in 2016 and 2017
11:38AM  Top 5 profitable Biotech stocks : September 23, 2016
11:10AM  The Factors behind Gileads Discounted Valuation
10:44AM  Gilead (GILD) Stock Higher, Citigroup: Hepatitis C Drug Sales Improving
10:04AM  What Are Analysts Recommendations for Gilead Sciences?
09:36AM  Gilead Sciences: Are Hepatitis C Sales Getting Better? at Barrons.com
09:07AM  The Cheapest Stocks in Biotech at Motley Fool
08:08AM  Gilead Sciences Focuses on a Strong Inorganic Growth Strategy
07:20AM  Why Is Gilead Sciences Trading at a Cheap Valuation?
07:20AM  Gilead Sciences: High Gross Margins despite Weak Sales
07:20AM  Analyzing Gilead Sciences Stock Performance
Sep-22-16 05:59PM  Final Trade: GILD, TWTR & more
05:42PM  Gilead diving into M&A?
04:35PM  Gilead, Allergan Seen Trailing Intercept In Ongoing NASH Battle
04:20PM  Gilead Sciences Inc.'s Biggest Win in 2016 So Far at Motley Fool
04:07PM  Will Gilead Make a Good Fit for Allergan? (GILD) at Investopedia
03:11PM  Gilead Ends Bowel Disease Treatment Trials (GILD) at Investopedia
11:53AM  Gilead Sciences: Another Blow to R&D Strategy at Barrons.com
11:51AM  Gilead Sciences, Inc. Value Analysis (NASDAQ:GILD) : September 22, 2016
11:20AM  Gilead Sciences (GILD) Stock Lower Despite Bullish Gabelli Note
10:48AM  The Pros and Cons of Buying Gilead Sciences Stock at Motley Fool
10:32AM  Gilead Sciences: A Hidden Asset? at Barrons.com
10:26AM  Allergan is Not Going to Buy Gilead at Bloomberg
08:04AM  Moves in Cancer Therapeutics among Recent Developments for Ionis
07:51AM  Gilead to Stop GS-5745 Development for Ulcerative Colitis
05:53AM  Is Galectin The Next Takeover Target for the Biotech World?
Sep-21-16 05:00PM  Gilead Terminates Phase 2/3 Study of GS-5745 in Patients With Ulcerative Colitis Business Wire
03:16PM  Biotech: Why NASH is So Hot Right Now at Barrons.com
10:37AM  Gilead Sciences (GILD) Stock Lower, Gabelli: Allergan Could Be Buyer
10:30AM  Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers'
09:38AM  Gilead Sciences: Allergan's Next Target? at Barrons.com
08:08AM  Gilead Sciences, Inc. breached its 50 day moving average in a Bullish Manner : GILD-US : September 21, 2016
07:21AM  Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma
12:00AM  Big Pharma, Biotech Attack NASH Liver Illness From All Sides at Bloomberg
Sep-20-16 08:14PM  Potential Acquisitions for Gilead Sciences (GILD) at Investopedia
05:09PM  GILEAD SCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob
03:28PM  Biotech buyout: The next big liver disease
03:16PM  Here's a Reason Why Gilead (GILD) Stock Is Gaining Today
01:47PM  Gilead Is in Breakout Mode
01:30PM  This Hated Pharma Stock Has A Bright Future
12:09PM  The 5 Top-Selling Drugs In The World
12:00PM  Gilead Sciences: Why Allergan's Tobira Purchase is Wonderful, Wonderful News at Barrons.com
07:16AM  How Safe Is Gilead Sciences Inc. and Its Dividend? at Motley Fool
Sep-19-16 03:56PM  Hateful Paper: Washed Out, Worth A Shot at Forbes
03:00PM  After Losing Medivation, Who Is Gilead Going After Next? at Forbes
Sep-18-16 03:18PM  How Risky Is Gilead Sciences Inc.? at Motley Fool
Sep-17-16 02:27AM  [$$] Will Bayer's Takeover of Monsanto Be a Bust? at Barrons.com
Sep-16-16 04:15PM  Gilead Notes Issue to Close on Sept. 20 (GILD) at Investopedia
03:27PM  Gilead ready to shop?
03:00PM  You've Got the Brains, I've Got the Book, Let's Make Lots of Money
11:21AM  Gilead (GILD) Stock Down, Jefferies: $5 Billion Debt Offering Suggests 'Imminent' Deal
08:12AM  Are We Unprepared For Another Ebola Outbreak? at Forbes
Sep-15-16 10:01PM  Gilead Prices $5 Billion of Senior Unsecured Notes Business Wire
11:18AM  Gilead Sciences, Inc. -- Moody's rates Gilead's notes A3; stable outlook at Moody's
11:17AM  Gilead's Pipeline, Maligned by Investors, Still Packed With 4Q Clinical Trial Readouts
09:31AM  5 Stocks Expected to Outperform this Week According to Forcerank
09:30AM  The Zacks Analyst Blog Highlights: TOTAL, Oracle and Gilead Sciences
Sep-14-16 07:45PM  Gilead Remains Promising Despite Recent Declines (GILD) at Investopedia
02:44PM  Street Talk: GILD, FCX & more
02:33PM  Major Analyst Action Surrounding These Stocks Today at Insider Monkey
12:52PM  New Oracle, Gilead Sciences & TOTAL Research Reports
12:15PM  4 Jefferies Stealth Stock Picks for a Very Volatile Market at 24/7 Wall St.
11:19AM  Untreated: Hepatitis C, America's Prison Epidemic at MarketWatch
10:56AM  Will Gilead Sciences (GILD) Stock Be Affected by Lower Price Target?
10:48AM  Credit Suisse Cuts Gilead Price Target To $95
10:42AM  You'll Never Guess Which Pharma Could Knock Gilead Sciences Off Its HIV Throne at Motley Fool
10:11AM  Gilead Sciences: It's What I Do, Not What I Say at Barrons.com
09:17AM  The Market In 5 Minutes: Huge FDA News, Major Mid-Week M&A
Sep-13-16 09:57PM  [$$] Takeda earmarks $15bn for US pharma acquisitions at Financial Times
04:00PM  Gilead Sciences: Cheap Growth or Value Trap?
01:32PM  Why Gilead Sciences Loves PARPAnd You Should Too at Barrons.com
09:35AM  J&J Files for Single-Tablet Regimen of HIV Drug Prezista in EU
08:01AM  Buy Gilead and Wait for the Rebound
07:11AM  Billionaire Battleground: Is It Time to Buy or Sell Gilead Sciences? at Motley Fool
07:05AM  Short Sellers Run for Cover From Major Biotechs at 24/7 Wall St.
12:06AM  [$$] High Cost of New Hepatitis C Drugs Strains Prison Budgets, Locks Many Out of Cure at The Wall Street Journal
12:04AM  Scientists Honored for Hep C Research at The Wall Street Journal
Sep-12-16 03:32PM  Biotech: Four Catalysts for Four Stocks at Barrons.com
03:15PM  Gilead Sciences (GILD) Stock Up, CEO Milligan Talks M&A Strategy
01:40PM  Buy Gilead Sciences for a 42% Profit? What You Need to Know at Motley Fool
11:59AM  Is Clovis Oncology Still a Strong Buy? at Motley Fool
09:05AM  Top Analyst Upgrades and Downgrades: Colgate-Palmolive, Gilead, Navistar, Occidental, Pandora, Wal-Mart and More at 24/7 Wall St.
08:35AM  5 Questions and Answers Take a Measure of Biotech Investor Sentiment
08:18AM  Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds at Motley Fool
06:21AM  Coverage initiated on Gilead Sciences by Berenberg
Sep-11-16 11:53AM  This Could Save Medicare at Least $16 Billion a Year, but the Agency Is Barred From Doing It at Motley Fool
Sep-10-16 10:05AM  Major Blue Chip Analyst Upgrades and Downgrades in Apple, Intel, Caterpillar, Gilead, JPMorgan and Nike at 24/7 Wall St.
Sep-09-16 04:33PM  [$$] Would Gilead Pick Up Tesaro's PARP? at Barrons.com
03:46PM  Gilead Sciences: What is PARP? at Barrons.com
Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company's products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alton Gregg HEVP Comm&Acs ALA, Corp&Med AffSep 22Sale81.845,000409,220132,964Sep 26 04:54 PM
MILLIGAN JOHN FPresident and CEOSep 06Option Exercise20.7470,0001,451,8001,128,963Sep 08 01:35 PM
MILLIGAN JOHN FPresident and CEOSep 06Sale77.7470,0005,442,0801,058,963Sep 08 01:35 PM
MARTIN JOHN CExecutive ChairmanSep 01Option Exercise16.40100,0001,639,5003,231,096Sep 06 02:40 PM
MARTIN JOHN CExecutive ChairmanSep 01Sale77.48100,0007,748,3633,131,096Sep 06 02:40 PM
Lofton Kevin EDirectorAug 24Sale81.973,500286,8990Aug 25 05:05 PM
MILLIGAN JOHN FPresident and CEOAug 01Option Exercise20.7470,0001,451,8001,128,963Aug 03 04:53 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Option Exercise39.132,00078,25564,305Aug 03 04:48 PM
MARTIN JOHN CExecutive ChairmanAug 01Option Exercise16.40100,0001,639,5004,119,727Aug 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsAug 01Sale79.812,000159,62062,305Aug 03 04:48 PM
MARTIN JOHN CExecutive ChairmanAug 01Sale80.50100,0008,049,7854,019,727Aug 03 04:51 PM
MILLIGAN JOHN FPresident and CEOAug 01Sale70.9470,0004,965,5901,058,963Aug 03 04:53 PM
Carter Paul RutherfordEVP Commercial OpsJul 31Option Exercise0.002,500063,622Aug 02 04:43 PM
MILLIGAN JOHN FPresident and CEOJul 05Option Exercise16.40112,0001,836,2401,170,963Jul 07 02:50 PM
MILLIGAN JOHN FPresident and CEOJul 05Sale84.33112,0009,444,9211,058,963Jul 07 02:50 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Option Exercise24.912,00049,81063,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Option Exercise16.40100,0001,639,5004,119,727Jul 06 01:28 PM
Carter Paul RutherfordEVP Commercial OpsJul 01Sale83.122,000166,25061,122Jul 06 01:26 PM
MARTIN JOHN CExecutive ChairmanJul 01Sale84.73100,0008,472,5234,019,727Jul 06 01:28 PM
MILLIGAN JOHN FPresident and CEOJun 06Option Exercise16.40112,0001,836,2401,170,963Jun 08 06:59 PM
MILLIGAN JOHN FPresident and CEOJun 06Sale86.94112,0009,736,7791,058,963Jun 08 06:59 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Option Exercise24.912,00049,81063,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Option Exercise16.40100,0001,639,5004,119,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsJun 01Sale87.022,000174,04061,122Jun 03 04:46 PM
MARTIN JOHN CExecutive ChairmanJun 01Sale86.72100,0008,671,9504,019,727Jun 03 04:51 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Option Exercise33.8857,0921,934,021118,214Jun 02 04:35 PM
Carter Paul RutherfordEVP Commercial OpsMay 31Sale86.8557,0924,958,60061,122Jun 02 04:35 PM
MARTIN JOHN CExecutive ChairmanMay 02Option Exercise16.40100,0001,639,5004,119,727May 04 02:44 PM
MILLIGAN JOHN FPresident and CEOMay 02Option Exercise16.40112,0001,836,2401,170,963May 04 02:49 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Option Exercise39.132,00078,25563,122May 04 04:23 PM
Carter Paul RutherfordEVP Commercial OpsMay 02Sale88.722,000177,44861,122May 04 04:23 PM
MILLIGAN JOHN FPresident and CEOMay 02Sale87.71112,0009,823,9541,058,963May 04 02:49 PM
MARTIN JOHN CExecutive ChairmanMay 02Sale87.82100,0008,781,6944,019,727May 04 02:44 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Option Exercise26.9935,874968,239177,964Apr 21 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsApr 19Sale100.0140,0004,000,574137,964Apr 21 01:28 PM
MILLIGAN JOHN FPresident and CEOApr 04Option Exercise16.40112,0001,836,2401,170,963Apr 05 07:30 PM
MILLIGAN JOHN FPresident and CEOApr 04Sale94.59112,00010,593,9041,058,963Apr 05 07:30 PM
MARTIN JOHN CExecutive ChairmanApr 01Option Exercise16.40100,0001,639,5004,119,727Apr 05 07:49 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Option Exercise24.912,00049,81063,122Apr 05 06:36 PM
Carter Paul RutherfordEVP Commercial OpsApr 01Sale91.342,000182,68061,122Apr 05 06:36 PM
Alton Gregg HEVP, Corp & Med AffairsApr 01Sale91.235,000456,158142,090Apr 05 07:45 PM
MARTIN JOHN CExecutive ChairmanApr 01Sale93.24100,0009,323,5074,019,727Apr 05 07:49 PM
Alton Gregg HEVP, Corp & Med AffairsMar 14Sale90.005,000450,000147,090Mar 15 07:31 PM
MARTIN JOHN CChairman and CEOMar 01Option Exercise16.40100,0001,639,5004,119,727Mar 03 02:47 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Option Exercise16.40112,0001,836,2401,170,963Mar 03 02:54 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Option Exercise24.912,00049,81063,122Mar 03 03:10 PM
Carter Paul RutherfordEVP Commercial OpsMar 01Sale87.902,000175,80061,122Mar 03 03:10 PM
MILLIGAN JOHN FPresident, COO and DirectorMar 01Sale87.79112,0009,832,9951,058,963Mar 03 02:54 PM
MARTIN JOHN CChairman and CEOMar 01Sale88.58100,0008,857,8544,019,727Mar 03 02:47 PM
Washington Robin LEVP, CFOFeb 16Sale90.726,250567,00084,688Feb 18 07:59 PM
Carter Paul RutherfordEVP Commercial OpsFeb 01Option Exercise39.142,00078,27150,783Feb 03 05:42 PM
MARTIN JOHN CChairman and CEOFeb 01Option Exercise16.40100,0001,639,5004,048,066Feb 03 05:43 PM
Carter Paul RutherfordEVP Commercial OpsFeb 01Sale82.322,000164,64048,783Feb 03 05:42 PM
MARTIN JOHN CChairman and CEOFeb 01Sale83.42100,0008,342,4753,948,066Feb 03 05:43 PM
Carter Paul RutherfordEVP Commercial OpsJan 04Option Exercise25.762,00051,52650,783Jan 06 05:08 PM
MARTIN JOHN CChairman and CEOJan 04Option Exercise16.40100,0001,639,5004,048,066Jan 06 05:21 PM
Carter Paul RutherfordEVP Commercial OpsJan 04Sale99.202,000198,40048,783Jan 06 05:08 PM
MARTIN JOHN CChairman and CEOJan 04Sale97.68100,0009,767,7083,948,066Jan 06 05:21 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSODec 15Option Exercise21.9970,0001,539,562197,936Dec 17 03:40 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSODec 15Sale102.4170,0007,168,741127,936Dec 17 03:40 PM
MILLIGAN JOHN FPresident and COODec 07Option Exercise14.50100,0001,450,2501,129,108Dec 09 02:14 PM
MILLIGAN JOHN FPresident and COODec 07Sale103.18100,00010,317,9771,029,108Dec 09 02:14 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Option Exercise24.3010,000242,950141,422Dec 03 01:57 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Option Exercise26.992,00053,98050,783Dec 03 01:56 PM
MARTIN JOHN CChairman and CEODec 01Option Exercise14.50150,0002,175,3754,098,066Dec 03 01:57 PM
MARTIN JOHN CChairman and CEODec 01Sale105.82150,00015,873,4673,948,066Dec 03 01:57 PM
Carter Paul RutherfordEVP Commercial OpsDec 01Sale106.382,000212,76048,783Dec 03 01:56 PM
Alton Gregg HEVP, Corp & Med AffairsDec 01Sale106.0112,0001,272,159129,422Dec 03 01:57 PM
Cogan John FrancisDirectorNov 24Option Exercise20.7115,000310,57559,309Nov 25 02:21 PM
Cogan John FrancisDirectorNov 24Sale105.9515,0001,589,19044,309Nov 25 02:21 PM
Whitley Richard JamesDirectorNov 24Sale106.4816917,99530,719Nov 25 02:22 PM
Whitley Richard JamesDirectorNov 23Sale107.182,863306,84530,888Nov 25 02:22 PM
Whitley Richard JamesDirectorNov 20Sale106.995,514589,91733,751Nov 25 02:22 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSONov 16Option Exercise23.7670,0001,662,850235,168Nov 18 12:32 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSONov 16Sale102.6570,0007,185,419165,168Nov 18 12:32 PM
MILLIGAN JOHN FPresident and COONov 09Option Exercise14.50100,0001,450,2501,129,108Nov 12 01:01 PM
MILLIGAN JOHN FPresident and COONov 09Sale107.66100,00010,765,6441,029,108Nov 12 01:01 PM
Washington Robin LEVP, CFONov 05Option Exercise0.006,000033,724Nov 09 05:41 PM
MARTIN JOHN CChairman and CEONov 02Option Exercise14.50150,0002,175,3754,098,066Nov 04 01:23 PM
Alton Gregg HEVP, Corp & Med AffairsNov 02Option Exercise24.3010,000242,950143,422Nov 04 02:41 PM
Carter Paul RutherfordEVP Commercial OpsNov 02Sale108.362,000216,71248,783Nov 04 04:27 PM
Washington Robin LEVP, CFONov 02Sale109.466,250684,15088,046Nov 04 04:21 PM
Alton Gregg HEVP, Corp & Med AffairsNov 02Sale109.3812,0001,312,507131,422Nov 04 02:41 PM
MARTIN JOHN CChairman and CEONov 02Sale109.42150,00016,413,0263,948,066Nov 04 01:23 PM
Cogan John FrancisDirectorOct 27Option Exercise20.7115,000310,57559,309Oct 28 08:13 PM
Cogan John FrancisDirectorOct 27Sale110.0015,0001,650,00044,309Oct 28 08:13 PM
Cogan John FrancisDirectorOct 26Option Exercise20.7115,000310,57559,309Oct 27 03:09 PM
Carter Paul RutherfordEVP Commercial OpsOct 26Sale110.061,500165,09248,783Oct 28 02:51 PM
Cogan John FrancisDirectorOct 26Sale110.0015,0001,650,00044,309Oct 27 03:09 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOOct 15Option Exercise23.6070,0001,652,248235,168Oct 16 05:32 PM
BISCHOFBERGER NORBERT WEVP, R&D and CSOOct 15Sale100.0570,0007,003,220165,168Oct 16 05:32 PM
MILLIGAN JOHN FPresident and COOOct 07Option Exercise14.50100,0001,450,2501,129,108Oct 08 02:06 PM
MILLIGAN JOHN FPresident and COOOct 07Sale99.22100,0009,921,5241,029,108Oct 08 02:06 PM
Alton Gregg HEVP, Corp & Med AffairsOct 05Option Exercise24.305,000121,475138,422Oct 07 01:22 PM
Alton Gregg HEVP, Corp & Med AffairsOct 05Sale100.005,000500,000133,422Oct 07 01:22 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Option Exercise24.305,000121,475140,422Oct 05 02:13 PM
MARTIN JOHN CChairman and CEOOct 01Option Exercise14.50150,0002,175,3754,098,066Oct 05 01:28 PM
Alton Gregg HEVP, Corp & Med AffairsOct 01Sale97.287,000680,930133,422Oct 05 02:13 PM
MARTIN JOHN CChairman and CEOOct 01Sale97.48150,00014,622,2893,948,066Oct 05 01:28 PM
Carter Paul RutherfordEVP Commercial OpsOct 01Sale98.592,000197,18048,783Oct 05 04:26 PM
V Visa Inc. daily Stock Chart
V [NYSE]
Visa Inc.
IndexDJIA S&P500 P/E40.46 EPS (ttm)2.02 Insider Own0.06% Shs Outstand2.36B Perf Week-0.85%
Market Cap193.14B Forward P/E24.63 EPS next Y3.32 Insider Trans0.00% Shs Float1.88B Perf Month1.86%
Income5.56B PEG2.52 EPS next Q0.73 Inst Own93.40% Short Float2.77% Perf Quarter11.74%
Sales14.39B P/S13.42 EPS this Y19.50% Inst Trans-0.94% Short Ratio5.97 Perf Half Y8.91%
Book/sh13.82 P/B5.92 EPS next Y19.07% ROA10.50% Target Price91.55 Perf Year16.58%
Cash/sh3.71 P/C22.07 EPS next 5Y16.07% ROE18.30% 52W Range65.76 - 83.79 Perf YTD6.07%
Dividend0.56 P/FCF63.68 EPS past 5Y30.70% ROI21.40% 52W High-2.36% Beta0.95
Dividend %0.68% Quick Ratio1.80 Sales past 5Y11.50% Gross Margin- 52W Low24.41% ATR0.90
Employees11300 Current Ratio1.80 Sales Q/Q3.20% Oper. Margin52.40% RSI (14)50.76 Volatility0.97% 1.04%
OptionableYes Debt/Eq0.48 EPS Q/Q-75.10% Profit Margin38.60% Rel Volume0.97 Prev Close82.54
ShortableYes LT Debt/Eq0.48 EarningsOct 20 AMC Payout23.40% Avg Volume8.72M Price81.81
Recom1.90 SMA20-0.32% SMA501.62% SMA2006.53% Volume8,486,752 Change-0.88%
Jul-22-16Reiterated Stifel Buy $86 → $91
Jun-06-16Resumed JP Morgan Overweight $88
Apr-20-16Reiterated Sun Trust Rbsn Humphrey Buy $85 → $100
Apr-15-16Initiated Compass Point Neutral $80
Feb-11-16Downgrade BofA/Merrill Buy → Neutral
Dec-17-15Initiated Sterne Agee CRT Buy
Dec-16-15Initiated UBS Buy $90
Nov-03-15Reiterated RBC Capital Mkts Outperform $82 → $91
Oct-22-15Resumed Wells Fargo Outperform
Oct-19-15Reiterated Oppenheimer Outperform $81 → $85
Aug-20-15Reiterated Barclays Overweight $80 → $85
Jul-24-15Reiterated Topeka Capital Markets Hold $66 → $70
Jul-24-15Reiterated RBC Capital Mkts Outperform $79 → $82
Jul-24-15Reiterated FBR Capital Mkt Perform $70 → $80
Jul-20-15Reiterated Oppenheimer Outperform $73 → $81
Jul-14-15Reiterated Bernstein Outperform $77 → $81
May-20-15Initiated Credit Agricole Outperform $77
Jan-30-15Reiterated Stifel Buy $280 → $308
Jan-30-15Reiterated Argus Buy $295 → $300
Jan-30-15Downgrade FBR Capital Outperform → Mkt Perform $260
Sep-26-16 05:34PM  Appeals court rules for American Express in fee dispute
01:22PM  Zacks: Visa's Growth Engages New Tech (V, AXP) at Investopedia
12:03PM  More trouble for banks?
10:24AM  Why that scuzzy ATM in the back of your favorite dive bar is about to disappear at MarketWatch
Sep-23-16 04:04PM  Paul Tudor Jones Purchases Stake in Visa
10:29AM  Visa's (V) Strategic Alliances Impress; Forex Risks a Drag
Sep-22-16 05:18PM  Amazon breaks $800
04:43PM  10 Stocks Dodge & Cox Keep Buying
07:05AM  Visa and Toronto Public Library Team up to Empower Youth With Financial Education Marketwired
Sep-21-16 01:42PM  KeyCorp (KEY), McDonalds Corporation (MCD): Clinton Group Makes Huge Moves On These 5 Finance and Consumer Stocks at Insider Monkey
06:53AM  Why I Think Costco Is Fairly Valued
04:25AM  U.S. carrier Verizon starts taking orders for new Samsung Note 7 phones
Sep-20-16 06:48PM  Cramer: Financial stocks that win, regardless of what the Fed says at CNBC
06:25PM  Cramer: Financial stocks that win, regardless of what the...
10:04AM  MasterCard Commands Premium Valuations on Core Growth
08:04AM  MasterCard Deploys Higher Rebates for Market Share
Sep-19-16 02:13PM  Why Visa Is a Solid Long-Term Dividend Play
12:58PM  Top trades for the 2nd half: Adobe, MasterCard & more
11:04AM  MasterCard Aggressive on International Acquisitions, Partnerships
10:05AM  MasterCard Processed Transactions Rise at a Record Pace
08:05AM  MasterCard Generates Strong Cash Flows, Less Leverage
Sep-17-16 12:29PM  Prepaid cards popularity as a bank alternative catches regulators eye at MarketWatch
02:44AM  [$$] Visa Consolidates Gains at Barrons.com
Sep-16-16 06:04PM  MasterCards International Dollar Volumes Dominate Growth
04:02PM  MasterCard Riding High on Acquisitions, Organic Growth
01:48PM  Five Credit Services Stocks With Strong Hedge Fund Support: Visa Inc. (V), MasterCard Inc (MA) & Others at Insider Monkey
01:15PM  Here's How Costco Customers Can Still Use Their American Express Card
10:45AM  Walmart is ramping up its battle with Visa
12:46AM  Finance Watch at The Wall Street Journal
Sep-15-16 04:13PM  PayPal Threat From Apple Pay Overdone, Rated Buy
04:07PM  Wal-Mart Canada to extend Visa ban to more stores from October 24
04:03PM  Wal-Mart Canada to extend Visa ban to more stores from Oct. 24
03:29PM  Is PayPal's Partnership With MasterCard a Good Deal? at Motley Fool
11:32AM  Wal-Mart Continues to Freeze Visa in Canada (WMT) at Investopedia
09:53AM  [$$] Wal-Mart Expands Move to Boycott Visa Cards in Canada at The Wall Street Journal
07:11AM  Wal-Mart Canada to Extend Visa Ban to All 16 Manitoba Stores at Bloomberg
07:00AM  Walmart Canada to extend Visa ban to more stores from Oct. 24
01:49AM  Indian DCB Bank collaborates With GI Technology, a Wirecard AG Subsidiary, to Launch mVisa in the Indian Retail Market PR Newswire
Sep-14-16 10:32AM  Visa (V) Rolls Out mVisa in Kenya to Expand Mobile Payments
Sep-13-16 02:57PM  Costco Wholesale Corporation's Best Business Segment in 2016 So Far at Motley Fool
01:17PM  MasterCard-PayPal Partnership Brings Solidarity to Legacy Players
09:43AM  Visa Agreements, Solid Financials Mean That It's Heading in the Right Direction for Investors
07:10AM  Nets' IPO pricing values Danish payments business at up to $4.8 bln Reuters
03:49AM  Visa Introduces Mobile-Money Product to Rival Safaricoms M-Pesa
03:49AM  Visa Begins Mobile-Money Service to Rival Safaricoms M-Pesa at Bloomberg
Sep-09-16 06:42PM  American Express Needs to Shake Off Its Lethargy
06:29PM  PayPal's Edge in the Mobile Wallet Space
01:04PM  MasterCard faces $18.6 billion UK lawsuit over fees
07:05AM  Visa Turns Spotlight on the Future of Commerce at the 2016 Toronto International Film Festival Marketwired
06:52AM  [$$] It's past midnight for the US share buyback bonanza at Financial Times
Sep-08-16 10:37AM  [$$] MasterCard Can Grow EPS by Double Digits at Barrons.com
10:04AM  Costco Challenges Citigroup, Some Are Still Bullish on the Bank
08:04AM  Amexs Valuations Imply Slower Growth and Uncertainty
07:07AM  Get Ready to Buy the Visa and MasterCard Breakouts -- Here's Why
Sep-07-16 04:05PM  Visa Inc. to Participate in Upcoming Investor Conference Business Wire
12:40PM  Paypal's Mastercard Deal Could Be First Step On Path To Peace With Payment Processors
11:04AM  Expectations Call for Amexs Yields, Repurchases to Rise in 2017
10:04AM  Global Network and Merchant Services Expected to Be Low in 3Q
08:04AM  Amexs Global Commercial Services Rising on Initiatives
Sep-06-16 05:51PM  MasterCard Follows Visa in Striking Deal to Avoid PayPal 'Steering'
04:12PM  [$$] New Cards Chip Away at Payment Companies at The Wall Street Journal
02:40PM  PayPal's Old Enemies Are Its New Pals at Bloomberg
02:21PM  Here's Why Baird Analysts Like MasterCard Better Than Visa
02:04PM  International Growth Continues to Offset Amexs Domestic Slide
01:06PM  The Truth Behind Costco's Credit Card Conversion at Motley Fool
01:04PM  American Express Faces Stiff Competition in the United States
10:44AM  American Expresss Revenues, Earnings Expected to Fall in 3Q, 4Q
08:46AM  Cisco, Intel And 3 Others Set New Highs As The Dow Lags at Forbes
07:53AM  PayPal, MasterCard reach deal for store payments
07:38AM  Visa checkout will be available or Braintree sellers in 2017 at MarketWatch
07:30AM  PayPals Braintree to Offer Visa Checkout Expanding Choice for Merchants and Consumers Business Wire
06:58AM  PayPal reaches deal with MasterCard for store payments - WSJ
Sep-05-16 10:04AM  Visa Commands Premium Valuations on Strong Performance
08:04AM  Growth in Visas Data Processing May Be Slowing
Sep-03-16 09:35AM  Better Buy: Square, Inc. vs. PayPal at Motley Fool
09:10AM  Turkey Says No Future Migration Help Without EU Visa-Free Deal
Sep-02-16 04:53PM  The Financial Brick Wall With Corporations
04:29PM  [$$] Verifone Pays for Headwinds at Barrons.com
04:09PM  VISA INC. Files SEC form 8-K/A, Financial Statements and Exhibits
02:55PM  Visas innovation exec reflects on IoT devices in Rio during local event at bizjournals.com
11:04AM  Visas Margins Expected to Contract Marginally in Fiscal 4Q16
10:23AM  Visa Puts Blockchain to the Test as Banks Mine Bitcoin Technology
10:04AM  Visa Europe Buy, Buyback Program Are Feathers in Visas Cap
08:23AM  The Morning Download: HP Enterprise Looks To Sell Software Unit at The Wall Street Journal
08:04AM  International Use to Boost Visas Fiscal 4Q16 Processed Transactions
Sep-01-16 11:00PM  Visa University Opens Its First International Campus in Singapore PR Newswire
07:04PM  Visa Strikes New Partnerships, Targets New Technologies
05:04PM  Spending to Grow Visas Payment Volumes by Double Digits in Fiscal 4Q16
03:09PM  Visa Expected to Post Growth in Fiscal 4Q16 on Integration, Spending
12:23PM  Visa Asks Banks to Participate in Blockchain Pilot for Transfers at Bloomberg
11:50AM  3 Great Stocks for Your Roth IRA at Motley Fool
10:57AM  Visa (V) Partners With Uber: A Better Ride On The Way?
10:51AM  Here's a Reason Why Visa (V) Stock Is Higher Today
12:34AM  [$$] Visa eyes new link in blockchain payments at Financial Times
Aug-31-16 11:30AM  7 Dividend Stocks That Owe You More Money at Kiplinger
Aug-30-16 03:00PM  Best in Class But Still a Bargain? It's True
02:31PM  India Considers $1.5 Million Residence Visa to Woo Investment at Bloomberg
01:21PM  Want Uber to Give You a Cheaper Ride? Visa's Happy to Help
09:30AM  The Zacks Analyst Blog Highlights: Pepsi, Visa, Marriot Vacations, Papa Johns and Zebra Technologies
09:00AM  Uber and Visa Introduce Local Offers Program to Help Merchants Tap Into Local Spend Opportunities Business Wire
Visa Inc., a payments technology company, operates an open-loop payments network worldwide. The company facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also provides a suite of digital, ecommerce, person-to-person payments, and mobile products and services. In addition, it offers merchant gateway services for ecommerce merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. The company provides its services under the Visa, Visa Electron, Interlink, and PLUS brands. Visa Inc. has a strategic alliance with Bottomline Technologies. The company was incorporated in 2007 and is headquartered in San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RICHEY ELLENVICE CHAIR RISK & PUB POLICYFeb 10Sale70.0039,3482,754,36049,996Feb 11 05:13 PM
PPG PPG Industries, Inc. daily Stock Chart
PPG [NYSE]
PPG Industries, Inc.
IndexS&P 500 P/E18.89 EPS (ttm)5.41 Insider Own0.38% Shs Outstand266.28M Perf Week1.05%
Market Cap27.20B Forward P/E14.99 EPS next Y6.81 Insider Trans-4.79% Shs Float265.21M Perf Month-4.32%
Income1.46B PEG2.13 EPS next Q1.71 Inst Own74.40% Short Float1.31% Perf Quarter3.89%
Sales15.30B P/S1.78 EPS this Y30.50% Inst Trans-0.09% Short Ratio2.33 Perf Half Y-6.93%
Book/sh20.01 P/B5.10 EPS next Y10.14% ROA8.50% Target Price123.11 Perf Year17.35%
Cash/sh6.27 P/C16.30 EPS next 5Y8.87% ROE28.40% 52W Range81.71 - 116.12 Perf YTD4.54%
Dividend1.60 P/FCF36.41 EPS past 5Y17.20% ROI15.80% 52W High-12.04% Beta1.47
Dividend %1.57% Quick Ratio1.20 Sales past 5Y2.70% Gross Margin44.80% 52W Low25.01% ATR1.54
Employees46600 Current Ratio1.60 Sales Q/Q-0.90% Oper. Margin14.30% RSI (14)44.21 Volatility1.25% 1.46%
OptionableYes Debt/Eq0.96 EPS Q/Q12.10% Profit Margin9.60% Rel Volume0.62 Prev Close103.27
ShortableYes LT Debt/Eq0.83 EarningsOct 20 BMO Payout27.20% Avg Volume1.50M Price102.14
Recom1.80 SMA20-1.66% SMA50-2.58% SMA200-1.11% Volume928,392 Change-1.09%
Jul-26-16Upgrade Seaport Global Securities Accumulate → Buy $125 → $130
Jun-23-16Upgrade Longbow Neutral → Buy
Mar-22-16Resumed Credit Suisse Outperform
Jan-22-16Reiterated Deutsche Bank Buy $110 → $105
Jan-05-16Initiated Seaport Global Securities Accumulate $115
Nov-25-15Reiterated RBC Capital Mkts Outperform $115 → $129
Oct-16-15Upgrade UBS Neutral → Buy $122
Oct-16-15Reiterated Barclays Equal Weight $120 → $115
Oct-12-15Upgrade Goldman Neutral → Buy $107 → $113
Sep-14-15Reiterated RBC Capital Mkts Outperform $126 → $115
Sep-08-15Reiterated RBC Capital Mkts Outperform $145 → $126
Jan-16-15Reiterated Argus Buy $238 → $271
Oct-17-14Reiterated RBC Capital Mkts Outperform $250 → $243
Oct-09-14Initiated RBC Capital Mkts Outperform $250
Jul-01-14Reiterated Deutsche Bank Buy $220 → $235
Apr-25-14Reiterated Argus Buy $216 → $224
Apr-21-14Reiterated Deutsche Bank Buy $213 → $220
Dec-06-13Reiterated Deutsche Bank Buy $195 → $210
Jul-22-13Reiterated UBS Neutral $148 → $156
Jul-22-13Reiterated RBC Capital Mkts Outperform $160 → $176
Sep-26-16 05:52PM  Chemours Inaugurates New TiO2 Production Line at Altamira in Mexico
Sep-23-16 02:00PM  PPG Industries to Sell Interest in PFG Fiber Glass JVs
Sep-22-16 08:11AM  PPG reaches agreement to divest its ownership interest in PFG fiber glass joint ventures Business Wire
Sep-20-16 10:34AM  PPG Declares Launch of Tribrid Lenses in North America
07:30AM  PPG Completes COLORFUL COMMUNITIES Project at Jana Babáka Primary School in Brno, Czech Republic Business Wire
Sep-19-16 05:04PM  PPG Putting Its Finishing Touch on New Honda Models
01:11PM  PPG Begins COLORFUL COMMUNITIES Project at Jahn Ferenc Hospital in Budapest Business Wire
Sep-16-16 12:48PM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition
Sep-15-16 07:01PM  Cramer: When in Doubt, Don't Go With the Apocalypse
Sep-14-16 08:09AM  PPG Industries Introduces Advanced Sound Absorbing Roving
Sep-12-16 02:35PM  PPG Completes COLORFUL COMMUNITIES Project at Thomas Edison Birthplace Museum in Ohio Business Wire
02:04PM  PPG Displayed Marine Coatings Technology at Industry Conference
01:39PM  PPG Industries, Inc. Value Analysis (NYSE:PPG) : September 12, 2016
11:04AM  A Quick Look into Valspars Valuations versus Peers
08:20AM  PPG Industries to Exhibit Packaging Coatings in New York City
Sep-09-16 06:04PM  Why Did Valspar Miss 3Q16 Analyst Revenue Estimates?
08:31AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : September 9, 2016
Sep-07-16 07:27AM  PPG Industries Exhibits Premium Marine Coatings at SSM
Sep-06-16 01:48PM  PPG Completes COLORFUL COMMUNITIES Project at Flying Horse Farms Business Wire
11:33AM  Sherwin-Williams Chooses Poised Taupe as 2017 Color of the Year
11:33AM  PPG Brand Announces 2017 Color of the Year
09:37AM  Fitch Maintains PPGs Long-Term Outlook: Stable
Sep-05-16 07:09AM  PPG Industries (PPG) Poised on Cost Measures, Acquisitions
Sep-01-16 01:40PM  Ohio Environmental Protection Agency Honors PPG Manufacturing Facility in Delaware, Ohio Business Wire
Aug-31-16 11:33AM  PPG Completes Four COLORFUL COMMUNITIES Projects in Pittsburgh Business Wire
09:08AM  PPG Industries' (PPG) Brands Unveil 2017 Color of the Year
Aug-30-16 06:17AM  PPG Industries to Display Coatings at Intermodal Expo
Aug-29-16 08:01AM  Silverado Named PITTSBURGH PAINTS & STAINS 2017 Color of the Year Business Wire
07:55AM  GLIDDEN Paint Names Byzantine Blue as 2017 Color of the Year Business Wire
07:50AM  Cloudberry Named Top Color for 2017 by OLYMPIC Paints and Stains Brand Business Wire
Aug-26-16 08:54AM  PPG Industries Unveils New Color Palette from SICO Paint
Aug-25-16 10:27AM  ETFs with exposure to PPG Industries, Inc. : August 25, 2016
07:24AM  PPG Industries to Display Advanced Coatings at Vehicle Expo
Aug-24-16 08:10AM  PPG Industries, Inc. breached its 50 day moving average in a Bullish Manner : PPG-US : August 24, 2016
06:29AM  PPG Industries' Paints Brand Launches Portal for Homeowners
Aug-22-16 05:53PM  Premiere Dividend Growth Stocks: Is There Any Value? Part 1
Aug-18-16 04:15PM  PPG PAINTS Brand Launches Preferred Homeowner Portal, Offers Paint Discounts to New-Home Buyers Business Wire
07:59AM  PPG Industries (PPG) Unveils New Fiber Glass Products
Aug-17-16 02:02PM  PPG Industries' Stock Split History: Why Investors Might Not See Another Split for a Long Time at Motley Fool
Aug-15-16 10:09AM  PPG Industries to Display Coatings Range at Construct 2016
Aug-14-16 07:20PM  5 Basic Materials Companies That Billionaires Are Fond Of at Insider Monkey
Aug-11-16 01:04PM  ETFs with exposure to PPG Industries, Inc. : August 11, 2016
05:49AM  PPG Industries (PPG) Opens New Distribution Center in Mexico
Aug-10-16 08:29AM  PPG Industries (PPG) to Upgrade Chester Fiber Glass Facility
Aug-09-16 02:34PM  These 5 Companies Will Probably Increase Their Dividends Soon
Aug-08-16 09:06AM  Reviewing LyondellBasells Valuations after Its 2Q16 Earnings
08:11AM  PPG Completes COLORFUL COMMUNITIES Project in Soborg, Denmark Business Wire
Aug-05-16 01:20PM  Why Did LyondellBasells 2Q16 Revenues Miss Analysts Estimates?
Aug-04-16 01:09PM  PPG Announces Four COLORFUL COMMUNITIES Projects in Pittsburgh Business Wire
08:11AM  PPG Opens Distribution Center in Hermosillo, Mexico Business Wire
02:35AM  Pro-Pac Packaging Ltd. :PPG-AU: Earnings Analysis: For the six months ended December 31, 2015 : August 4, 2016
Aug-03-16 01:11PM  PPG Named Raw Materials Quality Supplier of Year by FCA US LLC Business Wire
11:06AM  Why Dows Performance Materials and Chemicals Revenue Fell
08:11AM  PPG to Invest $20 Million to Upgrade Chester, South Carolina, Fiber Glass Plant Business Wire
Aug-02-16 11:07AM  Dow Chemicals 2Q16 Earnings Proved Analysts Estimates Wrong
Aug-01-16 09:11AM  Albemarle: How Much Net Profit Margin Are Analysts Predicting?
Jul-28-16 01:04PM  PPG INDUSTRIES INC Financials
11:04AM  Will PPG Industries 2Q Earnings Paint a Rosy Valuation Picture?
09:05AM  Will PPG Industries Glass Segment Cease to Exist in 3Q16?
06:00AM  Jim Cramer's Top Takeaways: Waste Management, Apple, PPG Industries, Centene
Jul-27-16 07:00PM  Cramer Remix: These stocks are the worst performers in the entire market at CNBC
11:07AM  PPG Industries Industrial Coatings Segment Topped Market Growth in 2Q16
09:10AM  Why PPG Industries 2Q16 Revenue from Performance Coatings Fell
Jul-26-16 11:34AM  Europe, China, and India Sales Rose, but Not Enough Not Help PPG Industries
11:34AM  How PPG Industries Managed to Miss Analysts 2Q16 Estimates
09:17AM  PPG Industries upgraded by Seaport Global Securities
08:29AM  PPG Industries, Inc. breached its 50 day moving average in a Bearish Manner : PPG-US : July 26, 2016
Jul-25-16 01:03PM  ETFs with exposure to PPG Industries, Inc. : July 25, 2016
Jul-22-16 01:04PM  Where Do Celanese Valuations Stand before Its 2Q16 Earnings Report?
12:39PM  PPG Industries, Inc. :PPG-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016
11:00AM  PPG INDUSTRIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements
Jul-21-16 06:09PM  Edited Transcript of PPG earnings conference call or presentation 21-Jul-16 6:00pm GMT
03:05PM  PPG Industries' Stock Stumbles as It Signals Times Are Changing
12:21PM  PPG INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition
12:17PM  PPG sells glass operations to Vitro SAB
10:07AM  [$$] PPG to Shed Flat-Glass Operations at The Wall Street Journal
10:02AM  PPG Directors Announce Quarterly Dividend of 40 Cents Per Share Business Wire
09:41AM  Healey Joins PPG Board of Directors Business Wire
09:01AM  PPG Industries (PPG) Beats on Q2 Earnings, Lags Revenues
09:01AM  Bunch to Retire as PPG Executive Chairman, CEO McGarry Elected to Succeed Business Wire
08:42AM  PPG Industries' (PPG) Q2 Earnings Beat, Sales Trail
08:40AM  Mexico's Vitro to buy flat glass unit of PPG for $750 mln
08:29AM  PPG Reaches Agreement with Vitro for Sale of Flat Glass Operations Business Wire
07:07AM  Q2 2016 PPG Industries Inc Earnings Release - Before Market Open
07:03AM  PPG Industries beats 2Q profit forecasts
06:51AM  PPG Reports Second Quarter 2016 Financial Results Business Wire
Jul-19-16 08:13AM  Chemical Stocks' Earnings to Watch This Week: PPG, SCL, SXT
Jul-18-16 09:48AM  Coverage Initiated on Select Specialty Chemicals Stocks
08:50AM  PPG Industries (PPG): Can Q2 Earnings Pull a Surprise?
Jul-16-16 11:04AM  Can Celaneses Operating Cash Flows Reach New Highs in 2Q16?
10:14AM  4 Ridiculously Cheap Dividend Stocks To Buy Now - And 1 To Sell at Forbes
Jul-14-16 05:29PM  PPG Industries (PPG) Launches Printable Label Stock, Teslin
03:56PM  Can Celanese Outperform Analysts Revenue Estimates in 2Q16?
10:06AM  Should SWK Investors Worry about the Lower Construction Spending?
Jul-13-16 02:37PM  PPG Foundation Donates $10,000 to Boys and Girls Clubs of Delaware for Science, Math Programs Business Wire
Jul-12-16 10:06PM  Can Eastmans Additives & Functional Products Segment Deliver?
06:04PM  How Will PPGs Performance Coatings Business Perform in 2Q16?
07:11AM  PPG Works with HUMANITARIUM Science Centre in Poland to Sponsor Interactive Laboratory of Colours Business Wire
Jul-11-16 03:38PM  PPG Announces Executive Appointment Business Wire
Jul-07-16 09:11AM  PPG Honors 10 Excellent Suppliers Business Wire
PPG Industries, Inc. manufactures and distributes coatings, specialty materials, and glass products. It operates in three segments: Performance Coatings, Industrial Coatings, and Glass. The Performance Coatings segment provides coatings products for automotive and commercial transport/fleet repair and refurbishing; light industrial and specialty coatings for signs; coatings, sealants, and transparencies for commercial, military, regional jet and general aviation aircraft, and transparent armor for specialty applications; and chemical management services. This segment also offers protective and marine coatings and finishes for the protection of metals and structures to metal fabricators and heavy duty maintenance contractors, as well as to the manufacturers of ships, bridges, and rail cars; architectural coatings used by painting and maintenance contractors, and consumers for decoration and maintenance of residential and commercial building structures; and purchased sundries to painting contractors and consumers. The Industrial Coatings segment provides adhesives and sealants for the automotive industry; metal pretreatments and related chemicals for industrial and automotive applications; precipitated silicas for tire, battery separator, and other markets; substrates used in radio frequency identification tags and labels, e-passports, drivers' licenses, and identification cards; organic light emitting diode materials for use in displays and lighting; optical lens materials and photochromic dyes for optical lenses and color-change products. The Glass segment produces flat and fiber glass for use in commercial and residential construction, wind energy, energy infrastructure, transportation, and electronics industries. The company was founded in 1883 and is headquartered in Pittsburgh, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Option Exercise63.749,300592,76219,506Aug 08 03:45 PM
KNAVISH TIMOTHY MSr. VP, Automotive CoatingsAug 04Sale104.089,300967,93110,206Aug 08 03:45 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Option Exercise65.7630,4502,002,24069,044Jul 28 10:15 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentJul 26Sale106.6440,9504,367,01428,094Jul 28 10:15 AM
USHER THOMAS JDirectorApr 20Option Exercise0.001,09202,092Apr 22 03:30 PM
RICHENHAGEN MARTINDirectorApr 20Option Exercise0.001,092020,576Apr 22 03:25 PM
HOOPER MICHELE JDirectorApr 20Option Exercise0.001,092015,352Apr 22 03:16 PM
Sklarsky Frank SExecutive VP & CFOFeb 29Option Exercise0.0010,000024,467Mar 02 12:40 PM
BUNCH CHARLES EExecutive Chairman of BoardFeb 26Sale98.1746,2864,543,711732,911Mar 01 04:01 PM
RICHENHAGEN MARTINDirectorFeb 20Option Exercise0.001,750019,484Feb 23 08:44 AM
HOOPER MICHELE JDirectorFeb 20Option Exercise0.001,750014,260Feb 23 08:40 AM
BERGES JAMES GDirectorFeb 20Option Exercise0.001,750010,488Feb 23 08:20 AM
BUNCH CHARLES EExecutive Chairman of BoardNov 16Sale101.9416,2861,660,115720,070Nov 17 04:04 PM
NIEKAMP CYNTHIA ASr. VP, Automotive CoatingsOct 30Sale104.357,200751,33960,498Nov 03 01:02 PM
BUNCH CHARLES EExecutive Chairman of BoardOct 26Sale103.7512,0001,244,952736,356Oct 27 04:03 PM
SEKMAKAS VIKTORAS RExecutive Vice PresidentOct 19Option Exercise55.0111,916655,49940,178Oct 20 09:11 AM
SEKMAKAS VIKTORAS RExecutive Vice PresidentOct 19Sale100.9811,9161,203,27828,262Oct 20 09:11 AM
HON Honeywell International Inc. daily Stock Chart
HON [NYSE]
Honeywell International Inc.
IndexS&P 500 P/E18.36 EPS (ttm)6.32 Insider Own0.10% Shs Outstand760.87M Perf Week1.22%
Market Cap88.22B Forward P/E15.98 EPS next Y7.26 Insider Trans-61.04% Shs Float759.91M Perf Month-0.71%
Income4.93B PEG1.99 EPS next Q1.70 Inst Own77.40% Short Float0.51% Perf Quarter4.55%
Sales39.11B P/S2.26 EPS this Y13.30% Inst Trans-0.06% Short Ratio1.44 Perf Half Y4.69%
Book/sh24.59 P/B4.71 EPS next Y8.72% ROA10.00% Target Price128.11 Perf Year26.71%
Cash/sh9.16 P/C12.65 EPS next 5Y9.23% ROE27.00% 52W Range89.60 - 119.41 Perf YTD13.75%
Dividend2.38 P/FCF35.95 EPS past 5Y19.40% ROI16.00% 52W High-2.90% Beta1.06
Dividend %2.05% Quick Ratio1.00 Sales past 5Y3.60% Gross Margin31.30% 52W Low29.40% ATR1.45
Employees129000 Current Ratio1.30 Sales Q/Q2.20% Oper. Margin17.20% RSI (14)53.55 Volatility1.07% 1.27%
OptionableYes Debt/Eq0.75 EPS Q/Q10.20% Profit Margin12.60% Rel Volume0.96 Prev Close115.98
ShortableYes LT Debt/Eq0.51 EarningsOct 21 BMO Payout36.10% Avg Volume2.72M Price115.94
Recom1.90 SMA200.70% SMA500.16% SMA2005.41% Volume2,606,458 Change-0.03%
Apr-25-16Reiterated Stifel Buy $127 → $129
Apr-25-16Reiterated RBC Capital Mkts Outperform $121 → $122
Apr-18-16Reiterated Barclays Overweight $107 → $122
Feb-01-16Reiterated Stifel Buy $106 → $113
Dec-17-15Reiterated Oppenheimer Outperform $117 → $120
Nov-16-15Reiterated Barclays Overweight $103 → $104
Oct-20-15Reiterated Argus Buy $115 → $118
Oct-19-15Reiterated RBC Capital Mkts Outperform $121 → $120
Jul-31-15Reiterated Barclays Overweight $120 → $118
Jul-29-15Reiterated Barclays Overweight $115 → $120
Jul-21-15Reiterated Argus Buy $115 → $118
Jul-20-15Reiterated Stifel Buy $116 → $120
Jul-20-15Reiterated RBC Capital Mkts Outperform $116 → $122
May-15-15Reiterated Cowen Outperform $112 → $116
Jan-27-15Reiterated Argus Buy $106 → $115
Jan-22-15Initiated UBS Neutral $105
Dec-16-14Reiterated Stifel Buy $109 → $112
Nov-25-14Reiterated RBC Capital Mkts Outperform $105 → $116
Sep-17-14Resumed Stifel Buy $112
May-29-14Reiterated Oppenheimer Outperform $103 → $110
Sep-26-16 09:24PM  Honeywell Supports U.S. EPA's Program To Reduce Harmful Greenhouse Gas Emissions PR Newswire
09:12AM  Honeywell International, Inc. breached its 50 day moving average in a Bearish Manner : HON-US : September 26, 2016
Sep-25-16 01:04PM  Dont fire until you see the whites of their eyes
Sep-23-16 06:01PM  Sally Beauty Holdings & Versum Materials Set to Join the S&P MidCap 400; Others to Join S&P SmallCap 600 PR Newswire
02:11PM